Systems and methods for positioning a catheter

Abstract
A method for displaying a position of a medical device, such as a catheter, during insertion of the medical device into a patient is disclosed. In one example embodiment, the method includes obtaining a first set of detected position data relating to a location marker, then determining a possible first position of the location marker. A first confidence level relating to a match between the first set of detected position data and a first set of predicted position data is assigned. A determination is made whether the first confidence level meets or exceeds a first threshold. If the first confidence level meets or exceeds the first threshold, a determination is then made whether the first position of the location marker is within a first detection zone. If the first position of the location marker is within the first detection zone, the first position of the location marker is displayed.
Description
BRIEF SUMMARY

Briefly summarized, embodiments of the present invention are directed to a method for displaying a position of a medical device, such as a catheter, during insertion thereof into a patient.


In one example embodiment, the method includes obtaining a first set of detected position data relating to a location marker, then determining a possible first position of the location marker. A first confidence level relating to a match between the first set of detected position data and a first set of predicted position data is assigned. A determination is made whether the first confidence level meets or exceeds a first threshold. If the first confidence level meets or exceeds the first threshold, a determination is then made whether the first position of the location marker is within a first detection zone. If the first position of the location marker is within the first detection zone, the first position of the location marker is displayed.


These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates an embodiment of a catheter being advanced through the vasculature of a patient to a destination;



FIG. 2A illustrates an embodiment of a stylet including a magnetic location marker;



FIG. 2B illustrates an embodiment of a guidewire including a magnetic location marker;



FIG. 2C illustrates an embodiment of a stylet including an electromagnetic field-producing location marker;



FIG. 3 illustrates an embodiment of a tip location detector positioned proximate to the chest of a patient;



FIG. 4 illustrates the detector of FIG. 3 with a portion of an embodiment of a first detection zone and a portion of an embodiment of a second detection zone superimposed thereon;



FIG. 5 illustrates another embodiment of a detector with a portion of an embodiment of a first detection zone and a portion of an embodiment of a second detection zone superimposed thereon;



FIG. 6 illustrates an embodiment of a catheter tip within the first detection zone of the detector of FIG. 3;



FIG. 7 illustrates an embodiment of a display depicting the detector of FIG. 3;



FIG. 8 illustrates the display of FIG. 6 showing an embodiment of a marker symbol representing a location of a catheter tip relative to the detector of FIG. 3;



FIG. 9 illustrates an embodiment of a system configured to locate a marker and display a graphical representation of the marker;



FIG. 10 illustrates in simplified block format a tip location system that serves as one example environment in which embodiments of the present invention can be practiced;



FIG. 11 depicts various stages of a method for displaying a location marker associated with a medical device, according to one embodiment; and



FIG. 12 depicts various stages of a method for displaying the location marker associated with the medical device, according to one embodiment.





DETAILED DESCRIPTION OF SELECTED EMBODIMENTS

Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.



FIGS. 1-12 depict various features of embodiments of the present invention, which is generally directed to methods and systems for detecting a location of a catheter, or of a catheter placement device, within a patient. Certain of such methods and systems relate more particularly to the detection and graphical representation of a location of a catheter or catheter placement device. In some embodiments, the systems and methods can represent the location relatively accurately and/or can reduce the number of erroneous identifications of the location, as further described below.


With reference to FIG. 1, in certain embodiments, a catheter 10 can be inserted in a vasculature 20 of a patient 25. The catheter 10 can be advanced in a distal direction from an entry point 28 to a destination 30, such as a target site or a desired or predetermined location within the patient 25. The catheter 10 can thus be advanced along a path 35 through the patient. In some embodiments, the catheter 10 can comprise a peripherally inserted central catheter (“PICC”), a central venous catheter (“CVC”), or another suitable catheter or medical device. In some embodiments, the destination 30 for a distal end 50 of the catheter 10 is within the superior vena cava (“SVC”). In other embodiments, the catheter 10 can be advanced to other suitable destinations 30 within the patient 25.


For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Further, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”


In certain embodiments, the catheter 10 is operably associated with a location marker 40. The location marker 40 can be at the distal end 50 of the catheter 10, and in some embodiments, may be integrally formed therewith. The location marker 40 can comprise an energy emitter or field producer of any suitable variety, and can include one or more permanent magnets (e.g., rare earth magnets), electromagnetic coils, or other magnetized materials or structures. In yet other embodiments, the location marker can comprise ultrasonic emitters, electromagnetic field emitters, visible/infrared photon emitters, ionizing radiation emitters, etc.


In one embodiment, the location marker can be tracked using the teachings of one or more of the following U.S. Pat. Nos. 5,775,322; 5,879,297; 6,129,668; 6,216,028; and 6,263,230. The contents of the afore-mentioned U.S. patents are incorporated herein by reference in their entireties.


As mentioned, the location marker 40, when associated with the catheter 10 as described above, enables the distal end 50 of the catheter to be tracked during its advancement through the vasculature. The direction in which the catheter tip is pointing can also be ascertained, thus further assisting accurate catheter placement. The location marker 40 further assists the clinician in determining when a malposition of the catheter distal end 50 has occurred, such as in the case where the distal end has deviated from a desired venous path into another vein.


With reference to FIG. 2A, in some embodiments, the location marker 40 is included on a stylet 60. The stylet 60 can be preloaded into a lumen of the catheter 10 prior to advancing the catheter 10 through the vasculature 20 of the patient 25, and may extend substantially to the distal end 50 of the catheter 10 such that the location marker 40 is substantially co-terminal with the catheter distal end. In some embodiments, only a distal portion of the stylet 60 includes the location marker 40. For example, a discrete section of a distal portion of the stylet may include permanent magnetic materials. In other embodiments, a larger portion of the stylet can comprise permanent magnetic materials. In some embodiments, the stylet 60 is removed from the lumen of the catheter 10 once the distal end 50 of the catheter has been positioned at the destination 30.


In greater detail, the stylet 60 includes a proximal end 62 and a distal end 70. A handle 64 is included at the stylet proximal end 62, with a core wire 66 extending distally therefrom. A magnetic assembly of magnetic elements that form the location marker 40 in the present embodiment is disposed distally of the core wire 66. The magnetic assembly includes the one or more magnetic materials disposed adjacent one another proximate the stylet distal end 70 and encapsulated by tubing 68. In the present embodiment, a plurality of permanent magnetic elements is included, each element including a solid, cylindrically shaped ferromagnetic stacked end-to-end with the other magnetic elements. An adhesive tip 69 can fill the distal tip of the tubing 68 adjacent the magnetic elements of the location marker 40. This configuration is exemplary; other location marker configurations are also contemplated.


Note that in other embodiments, the magnetic elements described above may vary from the design in not only shape, but also composition, number, size, magnetic type, and position in the stylet, guidewire, etc. For example, in one embodiment, the plurality of ferromagnetic magnetic elements is replaced with an electromagnetic assembly, such as an electromagnetic coil, which produces an electromagnetic field for detection by the sensor. Another example of an assembly usable here can be found in U.S. Pat. No. 5,099,845 entitled “Medical Instrument Location Means,” which is incorporated herein by reference in its entirety. Yet other examples of stylets including magnetic elements that can be employed with the catheter tip location modality described herein can be found in U.S. application Ser. No. 11/466,602 filed Aug. 23, 2006, and entitled “Stylet Apparatuses And Methods Of Manufacture,” published as U.S. Publication No. 2007-0049846 which is incorporated herein by reference in its entirety. These and other variations are therefore contemplated by embodiments of the present invention. It should be appreciated herein that “stylet” as used herein can include any one of a variety of devices configured for removable placement within a lumen of the catheter to assist in placing a distal end of the catheter in a desired location within the patient's vasculature.


With reference to FIG. 2B, in another embodiment, the location marker 40 including a plurality of magnetic elements or other suitable structure is included on a distal portion of the guidewire 80 proximate a distal end 90 thereof. In this embodiment, the distal tip 90 of the guidewire 80 is advanced to the destination 30 within the patient 25. The catheter 10 can then be advanced over the guidewire 80 until the distal end 50 of the catheter 10 is at the destination 30. The guidewire 80 can then be removed from the patient 25.



FIG. 2C gives various details regarding a distal portion of a stylet 92 including the location marker 40 configured in accordance with one possible embodiment. A coil assembly 96 is included proximate a stylet distal end 94 and is operably connected to leads 96A. The leads 96A are in turn operably connected to corresponding circuitry in a tip location system (FIG. 10) configured to produce an electric pulse signal so as to enable the coil assembly 96 to be electrically pulsed during operation and produce an electromagnetic field having a predetermined frequency or pattern that is detectable by one or more sensors included in a detector placed proximate to the patient 25 (FIG. 3) during transit of the catheter through the vasculature when the coil assembly is within the detectable range of the sensor. Note that the coil assembly described herein is but one example of a field-producing element, or a component capable of producing an electromagnetic field for detection by the sensor. Indeed, other devices and assembly designs can be utilized here to produce the same or similar functionality.


The coil assembly 96 and leads 96A are disposed within tubing 98 that extends the length of the stylet 92. The coil assembly and leads can be protected in other ways as well. A core wire 99 can be included within the tubing 98 in one embodiment to offer stiffness and/or directional torqueability to the stylet 92. The core wire 99 in one embodiment includes nitinol and can extend to the distal end 94 of the stylet 92 or terminate proximal thereto.


With reference to FIG. 3, in certain embodiments, a tip location detector 100 is positioned adjacent or proximate to the patient 25 as the catheter 10 is advanced to the destination 30 within the patient vasculature. For example, in the illustrated embodiment, the detector 100 can be positioned on the chest of the patient 25.


The detector 100 includes in the present embodiment one or more sensors 110. Two sensors 110 are shown schematically in the illustrated embodiment. In some embodiments, the location detector 100 can include one or more, two or more, etc. sensors 110. For instance, in one embodiment, the detector 100 includes ten sensors 110 placed in a spaced-apart configuration within the detector body. The sensors 110 are configured to detect the location marker 40. For example, each sensor 110 can be configured to detect the strength of a magnetic field produced by the location marker 40 at the position of the sensor 110 and by so doing enable the system to calculate an approximate location and orientation of the location marker.


In some embodiments, the detector 100 defines one or more branches 120. In some embodiments, two branches 120a, 120b of the detector 100 extend upward and outward from a lower branch 120c such that the detector 100 is substantially “Y”-shaped. Terms such as “upper” and “lower” are used herein by way of convenience, and not limitation, to describe the embodiments depicted in the figures. Accordingly, the upper branches 120a, 120b are closer to the head of the patient 25 than is the lower branch 120c.



FIG. 3 illustrates an axis convention that will be used throughout the remainder of this disclosure by way of convenience and not limitation. In the illustrated embodiment, three dimensional Cartesian coordinate system is centered on the lower branch 120c of the detector 100. The positive portion of the X-axis runs toward the right of the page (i.e., toward the left side of the patient 25), the positive portion of the Y-axis runs toward the top of the page (i.e., toward the head of the patient 25), and the positive portion of the Z-axis extends directly out of the page (i.e., away from the chest of the patient 25). Accordingly, the portion of the Z-axis extends through the patient 25 such that a more negative Z-value is deeper within the patient relative to the detector 100.


In some embodiments, a portion of the detector 100 can be expected to be more sensitive to the initial detection of the location marker 40 than other portions of the detector 100. For example, in some embodiments, the location marker 40 may be expected to pass beneath (i.e., below, relative to the Z-axis) the branch 120a of the detector 100 before passing beneath other portions of the detector 100 as the catheter 10 is advanced toward the superior vena cava of the patient 25. In some embodiments, data processing algorithms based on such an expectation can be used to reduce or eliminate misidentification of a position of the location marker 40 or “false positive” identifications that represent something other than the marker 40.


With reference to FIG. 4, in some embodiments, the detector 100 is in communication with a processor 130. The processor 130 can comprise any suitable storage and/or computing device, such as, for example, a computer configured to run one or more programs, or a microprocessor. The processor 130 can be configured to receive data obtained by the detector 100 (e.g., via the sensors 110) and to process the data to determine a position of the location marker 40, as further described below. In some embodiments, the processor 130 utilizes detection zones in processing the data received from the detector 100 and/or in delivering a representation of the position of the location marker 40 for display. One possible environment in which the processor 130 is included is seen in FIG. 10, as described further below.


In some embodiments, the processor 130 utilizes a first detection zone 140 and a second detection zone 150. In some embodiments, the first detection zone 140 encompasses a relatively large portion of the upper branches 120a, 120b of the detector 100. For example, in some embodiments, the first detection zone 140 extends from a base portion of each branch 120a, 120b to a position above the detector 100 in the positive Y direction, beyond the detector 100 in both the positive and negative X directions, and below the detector 100 in the negative Z direction. As such, the first detection zone 140 and second detection zone 150 define imaginary rectangular volumes of space proximate the detector 100 that extend into the body of the patient 25. In one embodiment, for example, the size of the first detection zone 140 is about 28 centimeters (cm) in the X direction, about 10.5 cm in the Y direction, and about 8 cm in the Z direction. The size of the second detection zone 150 is about 23 cm in the X direction, about 15 cm in the Y direction, and about 11 cm in the Z direction. Other detection zone dimensions are also possible.


In other embodiments, the first detection zone 140 does not include the detector 100. For example, in some embodiments, the first detection zone 140 can be substantially as shown in FIG. 4, but begins at a position below the detector 100 (i.e., at a position in the negative Z direction), and extends toward more negative Z-values.


One or more of the first and second detection zones 140, 150 can include a portion of the path 35 along which the catheter 10 is advanced. In some embodiments, the first detection zone 140 includes a portion of the path 35 that is proximal of a portion of the path 35 that runs through the second detection zone 150. In other embodiments, only the first detection zone 140 may include a portion of the path 35.


In some embodiments, the first and second detection zones 140, 150 can overlap each other. For example, in the illustrated embodiment, the second detection zone 150 includes a portion of the upper branches 120a, 120b that is also included in the first detection zone 140. The first and second detection zones 140, 150 can define the same or different areas in any of the XY-, YZ-, or ZX-planes and can define the same or different volumes.


More or fewer detection zones are possible. Additionally, detection zones can define a variety of shapes, such as, for example, boxes, spheres, ellipsoids, and paraboloids. Detection zones may be suitably described in a variety of coordinate systems, such as, for example, Cartesian or polar coordinates.



FIG. 5 illustrates another embodiment of a detector 100 having an upper detection zone 160 and a lower detection zone 170 superimposed thereon. FIG. 5 provides approximate dimensions and approximate relative positions of the upper and lower detection zones 160, 170. In the illustrated embodiment, the detection zones 160, 170 begin at a position of about −1 centimeter from the origin of the Z-axis and terminate at a position of about −6 cm from the origin of the Z-axis.


Other dimensions than those illustrated in the instant embodiment are also possible. For example, one or more of the upper and lower detection zones 160, 170 can extend from about −1 centimeter to about −25 centimeters, from about −1 centimeter to about =15 centimeters, from about −1 centimeter to about −12 centimeters, or from about −1 centimeter to about −9 centimeters from the Z-origin. In some embodiments, the upper limit of the depth of one or more of the upper and lower detection zones 160, 170 can be within a range of between about 0 centimeters and −5 centimeters, and the lower limit of the depth of one or more of the first and second detection zones 160, 170 can be within a range of between about −5 centimeters and about −30 centimeters. Other ranges for the upper and lower detection zones 160, 170 are possible. The first and second detection zones 140, 150 can be defined in one embodiment by the same or different dimensions as the upper and lower detection zones 160, 170.



FIG. 6 depicts a catheter 10 having the location marker 40 positioned beneath the detector 100 of FIG. 4. A magnetic field produced by the location marker 40 is schematically illustrated by concentric circles. In the illustrated embodiment, the location marker 40 is within the first detection zone 140.


With reference to FIG. 7, in certain embodiments, the processor 130 can be in communication with a display device 200, such as, for example a graphical user interface on a screen (see also FIG. 10). In some embodiments, the display 200 includes a detector representation 210, which can depict a projection of the detector 100 in the XY-plane. A depth indicator 220 can depict a Z-coordinate of the location marker 40.


As shown in FIG. 8, in some embodiments, the display 200 can include a marker symbol 230 that represents a position of the location marker 40 relative to the detector 100 (compare FIG. 6), such as within a portion of the vasculature of the patient when the detector is positioned on the patient's chest. The marker symbol 230 can also indicate a direction in which the location marker 40 is moving or the direction that the location marker 40 is facing. For instance, in the view shown in FIG. 8, the location marker 40 indicates that the catheter 10 is generally advancing from the left side of the page toward the right side thereof. As further discussed below, in some embodiments, whether or not the marker symbol 230 is displayed and/or the position on the display 200 at which the marker symbol 230 is displayed is based on information received from the processor 130.


In some embodiments, the display 200 can include button icons 240 that correspond to buttons or controls located on a button control interface included in a console (FIG. 10) in which the display 200 is housed. Further informational or control icons 250 can be included on the display 200. In further embodiments, the display 200 comprises a touch screen such that a user can deliver instructions to the processor 130 and/or the tip location detector 100 via the buttons or controls appearing on the screen. Other systems and methods for providing instructions to the processor 130 and/or the tip location detector 100 are also possible.


With reference to FIG. 9, in certain embodiments, a tip location system 300 can include the detector 100, the processor 130, and/or the display 200. The system 300 can be configured to detect the location marker 40 and to display the marker symbol 230, as described above. In some embodiments, the detector 100 is positioned relative to the patient 25. The system 300 is then zeroed to calibrate to (or account for) local magnetic fields. In some embodiments, after the system 300 has been zeroed, the system 300 actively measures magnetic fields. For example, in an implementation where the location marker 40 includes a plurality of magnetic elements positioned at the distal end 70 of a stylet 60 pre-loaded in the catheter 10 (see the stylet 60 shown in FIG. 2A), the detector 100 can monitor or measure magnetic fields via the sensors 110 during transit of the catheter through the vasculature of the patient. The measurements can be obtained continuously, for example, or iteratively at regular or irregular intervals as determined by the processor 130 or other suitable control component of the system 300.


In some embodiments, a model 310 of the location marker 40 is stored in the system 300. For example, in some embodiments, the model 310 is stored in a memory portion of the processor 130 for access when needed. The model 310 can comprise magnetic strength patterns that are each representative of a magnetic field produced by the location marker 40 at one of a multitude of possible marker locations. In some embodiments, the processor 300 compares data received from the detector 100, which data relate to the position of the location marker 40 with respect to one or more of the detector sensors 110, with the model 310 to ultimately determine whether the location marker 40 is within one or more of the detection zones 140, 150.


In some embodiments, the processor 130 can execute a program or set of executable instructions that implements one or more algorithms for determining how well a data set of a possible location marker position gathered by the detector 100 corresponds with the model 310. The program can provide a confidence level regarding the data set. In some embodiments, the confidence level indicates how well such a data set and the model 310 match. In further embodiments, the confidence level indicates the degree of certainty that the location marker 40 is at a specific position. In still further embodiments, the confidence level represents how well a gathered data set and the model 310 match as well as the degree of certainty that the location marker 40 is at a specific position. The confidence level can be expressed as an absolute or a scalar value, in some embodiments. An example of a program that is suitable for use with certain embodiments described herein is software marketed under the trademark ZAP™, which is distributed by Lucent Medical Systems.


In certain embodiments, the processor 130 provides instructions to depict the marker symbol 230 (FIG. 8) corresponding to the detected position of the location marker 40 on the display 200 when certain conditions are met. For example, in some embodiments, after the system 300 has been zeroed or calibrated, in order for the display to initially depict the marker symbol 230, the center of the location marker 40 must be identified as being within the first detection zone 140 with a confidence level above a first threshold value (or with a confidence level within a first range). For example, in certain embodiments that use ZAP™ software, the center of the location marker 40 must be identified as being within the first detection zone 140 (which can, for example, be at a depth of between about 1 centimeter and about 8 centimeters below the detector 100), with a COST of less than or equal to 500. COST is a term associated with ZAP™ software that represents in one embodiment an absolute value of a comparative match between measured magnetic field data as detected by the detector 100 and predicted magnetic field data as computed by the processor 130. The COST value is on a reverse scale such that a lower value represents a relatively higher threshold value or level of confidence.


In some embodiments, multiple identification and validation sequences, or solution sequences, regarding a position of a possible location marker 40 are performed before the marker symbol 230 is initially displayed. For example, in some embodiments, the conditions relating to resolution of the possible location marker position with respect to the first and/or second detection zones 140, 150 and determination of a confidence level described in the preceding paragraph must be satisfied in eight consecutive sequences before the marker symbol 230 will initially be displayed. In other embodiments, the conditions must be met in five consecutive sequences before an initial display of the marker symbol 230. In certain of such embodiments, subsequent cycles may aid in pinpointing or converging on a more accurate location of the marker symbol 230, such that the marker symbol 230 may drift slightly after it is initially displayed. Other series of solution sequences are also possible.


After the initial display of the marker symbol 230, separate conditions may be implemented in order to continue displaying the maker symbol 230 after it has met the conditions to be displayed initially. For example in some embodiments, the marker symbol 230 will continue to be displayed if the center of the location marker 40 is within either the first detection zone 140 or the second detection zone 150 and if the confidence level is above a second threshold value (or within a second confidence range). In some embodiments, the second threshold value is lower then the first threshold value (i.e., the second threshold value can represent a lesser degree of confidence than does the first threshold value). For example, in certain embodiments that use ZAP™ software, the center of the location marker 40 must be identified as being within the first or second detection zones 140, 150 with a COST of less than or equal to 1000 in order for the marker symbol 230 to continue to be displayed.


In further embodiments, the first and second detection zones 140, 150 can be expanded in size after the initial identification of the location marker 40 and initial display of the marker symbol 230. For example, in some embodiments, the first and second detection zones 140, 150 extend between a depth of about 1 centimeter and about 8 centimeters below the detector 100 before the initial display of the marker symbol 230, and can extend between a depth of about 1 centimeter and about 12 centimeters below the detector after the initial display of the marker symbol 230. Of course, modification of the detection zone sizes in amounts different from those outlined above is also possible.


An initial display of the marker symbol 230 can occur after events other than or in addition to zeroing the system 300. For example, in some embodiments, the system 300 may be turned off after having displayed the marker symbol 230. Upon being turned on again, a subsequent showing of the marker symbol 230 can be referred to as an initial display of the marker symbol 230. In other embodiments, the system 300 can be reset without powering down such that a first display of the marker symbol 230 after the resetting event would be an initial display of the marker symbol 230.


In some embodiments, the system 300 can employ separate criteria for displaying the marker symbol 230 after the system 300 has tracked the position of the location marker 40, e.g., after initially displaying and continuing to display the marker symbol 230. For example, in some embodiments, if the location marker 40 is moved out of the sensing range of the detector 100, e.g., outside of the first and second detection zones 140, 150 and subsequently moved back into the sensing range, the tracking can start again if the detector 100 senses that the location marker 40 is within the first detection zone 140 or the second detection zone 150 and is above the first threshold value, e.g., COST is less than or equal to 500. Similarly, in some embodiments, if the system 300 loses the tracking of the location marker 40, e.g., fails to identify the position of the location marker 40 during a solution sequence, the tracking can commence again if the detector 100 senses that the location marker 40 is within the first detection zone 140 or the second detection zone 150 and is above the first threshold value.


In some embodiments, the system 300 may be preset such that the threshold values are fixed. In other embodiments, the system 300 can be altered by a user to vary one or more threshold values, as desired.



FIG. 10 depicts in simplified form an example implementation of a tip location system, i.e., the system 300 partially depicted in FIG. 9, in which embodiments of the present invention can be practiced. As shown, the system 300 generally includes a console 420, display 200, probe 440, and detector 100, each of which is described in further detail below. As mentioned above, the system 300 is employed to ultimately position a distal end 50 of the catheter 10 in a desired position within the patient vasculature. In one embodiment, the desired position for the catheter distal end 50 is proximate the patient's heart, such as in the lower one-third (⅓rd) portion of the SVC (FIG. 1). Of course, the system 300 can be employed to place the catheter distal end in other locations.


A processor 422, including non-volatile memory such as EEPROM for instance, is included in the console 420 for controlling system function during operation of the system 300, thus acting as a control processor. A digital controller/analog interface 424 is also included with the console 420 and is in communication with both the processor 422 and other system components to govern interfacing between the probe 440, detector 100, and other system components.


The system 300 further includes ports 452 for connection with the detector 100 and optional components 454 including a printer, storage media, keyboard, etc. The ports in one embodiment are USB ports, though other port types or a combination of port types can be used for this and the other interfaces connections described herein. A power connection 456 is included with the console 420 to enable operable connection to an external power supply 458. An internal battery 460 can also be employed, either with or exclusive of an external power supply. Power management circuitry 459 is included with the digital controller/analog interface 424 of the console to regulate power use and distribution.


The display 200 in the present embodiment is an LCD-based device, is integrated into the console 420, and is used to display information to the clinician during the catheter placement procedure. In another embodiment, the display may be separate from the console. In one embodiment, the console button interface 432 (FIGS. 1, 8C) and buttons included on the probe 440 can be used to control the display 200 and thus assist the clinician during the placement procedure.


In one embodiment the system 300 optionally includes the probe 40, which is employed in connection with ultrasound (“US”)-based visualization of a vessel, such as a vein, in preparation for insertion of the catheter 10 into the vasculature. Such visualization gives real time ultrasound guidance for initially introducing the catheter into the vasculature of the patient and assists in reducing complications typically associated with such introduction, including inadvertent arterial puncture, hematoma, pneumothorax, etc. After the catheter has been initially placed in the patient vasculature, the system 300 can be used to locate the distal end 50 of the catheter 10 via detection of a corresponding location marker, as has been described above. In one embodiment, another modality can be added to the system 300, wherein an ECG-based confirmation of correct catheter distal tip placement with respect to a node of the patient's heart is employed. Further details regarding the US, tip location, and ECG-based modalities of the system 300 can be found in U.S. application Ser. No. 12/323,273, filed Nov. 25, 2008, and entitled “INTEGRATED SYSTEM FOR INTRAVASCULAR PLACEMENT OF A CATHETER,” published as U.S. Publication No. 2009-0156926 which is incorporated herein by reference in its entirety.



FIG. 10 shows that the probe 440 further includes button and memory controller 442 for governing button and probe operation. The button and memory controller 442 can include non-volatile memory, such as EEPROM, in one embodiment. The button and memory controller 442 is in operable communication with a probe interface 444 of the console 420, which includes a piezo input/output component 444A for interfacing with a piezoelectric array included in the probe, and a button and memory input/output component 444B for interfacing with the button and memory controller 442.


Embodiments of the present invention may comprise a special purpose or general-purpose computer including computer hardware. Embodiments within the scope of the present invention also include computer-readable media for carrying or having computer-executable instructions or data structures stored thereon. Such computer-readable media can be any available media that can be accessed by a general purpose or special purpose computer. By way of example, and not limitation, computer-readable media can include physical (or recordable-type) computer-readable storage media, such as, RAM, ROM, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, non-volatile and flash memory, or any other medium which can be used to store desired program code means in the form of computer-executable instructions or data structures and which can be accessed by a general purpose or special purpose computer.


In this description and in the following claims, a “network” is defined as one or more data links that enable the transport of electronic data between computer systems and/or modules. When information is transferred or provided over a network or another communications connection (either hardwired, wireless, or a combination of hardwired or wireless) to a computer, the computer properly views the connection as a computer-readable medium. Thus, by way of example, and not limitation, computer-readable media can also include a network or data links which can be used to carry or store desired program code means in the form of computer-executable instructions or data structures and which can be accessed by a general purpose or special purpose computer.


Computer-executable instructions comprise, for example, instructions and data which cause a general purpose computer, special purpose computer, or special purpose processing device to perform a certain function or group of functions. The computer executable instructions may be, for example, binaries, intermediate format instructions such as assembly language, or even source code. Although the subject matter has been described in language specific to structural features and/or methodological acts, it is to be understood that the subject matter defined in the appended claims is not necessarily limited to the described features or acts described above. Rather, the described features and acts are disclosed as example forms of implementing the claims.


Those skilled in the art will appreciate that the embodiments of the present invention may be practiced in computing environments with one or more types of computer system configurations, including, personal computers, desktop computers, laptop computers, message processors, hand-held devices, multi-processor systems, microprocessor-based or programmable consumer electronics, network PCs, minicomputers, mainframe computers, mobile telephones, PDAs, pagers, and the like. Embodiments may also be practiced in distributed system environments where local and remote computer systems, which are linked (either by hardwired data links, wireless data links, or by a combination of hardwired and wireless data links) through a network, both perform tasks. In a distributed system environment, program modules may be located in both local and remote memory storage devices.


Thus, in one embodiment, and as depicted in FIG. 11, a method 500 for displaying a position of a medical device includes calibrating the system 300 at stage 510. At stage 520, a first set of detected position data relating to a possible first position of a location marker is obtained. As has been described, the position data can relate to an X-Y-Z-coordinate on a Cartesian coordinate axis grid centered on or proximate to the detector 100, as shown in FIG. 4. In the present embodiment, the position data includes data from the magnetic field produced by the magnetic assembly of the location marker of the stylet as sensed by each of the sensors 110 of the detector 100. These data are forwarded to the processor 130 of the system 300.


At stage 525, the possible first position of the location marker is determined. In one embodiment, the possible first position relates to the initial detection of the location marker by the system and is estimated by a neural net functionality provided by the processor 130 or other suitable component of the system. In brief, the neural net functionality continually monitors detected position data and provides a best guess of the position of the location marker. In the present embodiment, the neural net functionality is pre-programmed, or “trained,” with sample location marker position data, i.e., magnetic field data, for a variety of possible location marker positions and orientations with respect to the detector 100. This training enables the neural net to make a best fit determination between its pre-programmed sample position data and the detected position data obtained in stage 520 to determine a possible first position of the location marker. Determination of the possible first position of the location marker in this stage is made in the present embodiment by the processor 130 or other suitable component via execution of the ZAP™ Software.


At stage 530, a first confidence level relating to a match between the first set of detected position data and a first set of predicted position data relating to the possible first position of the location marker is assigned. The predicted position data in the present embodiment is provided by the processor 130 or other suitable component via execution of the ZAP™ Software, which calculates the predicted data based on physics-based characteristics of the location marker (in the present embodiment, a stack of magnetic elements as seen in FIG. 2A) assumed to be positioned at the possible first position. The resulting first set of predicted position data includes data for each sensor of the detector on the chest of the patient and is compared to the corresponding first set of detected position data for each sensor. This comparison yields the first confidence level, which is a quantitative, absolute value indicating the degree of matching between the detected data obtained at stage 520 and the predicted data. As has been discussed above, the COST value produced by the ZAP™ Software is one example of a confidence level that can be employed in the present method 500. Again, further details regarding the ZAP™ Software and the COST value are given in one or more of U.S. Pat. Nos. 5,775,322, 5,879,297, 6,129,668, 6,216,028, and 6,263,230, each of which is incorporated herein by reference in its entirety. Of course, other algorithms utilizing other confidence level configurations can also be used.


In one embodiment, stages 525 and 530 above are iteratively executed in order to better pinpoint the possible first position of the location marker. With each iteration, the possible first position is modified, which in turn modifies the set of predicted position data, in the interest of better matching the predicted data with the detected position data obtained at stage 520. This in turn increases the first confidence level, i.e., reduces the COST value in the present embodiment where the ZAP™ Software is employed. Such an iterative method is also referred to as a convergence algorithm. Once a minimum COST value is obtained via the convergence algorithm, the method can proceed. In other embodiments, a predefined number of iterations can be performed; in still other embodiments no additional iterations are performed.


At stage 540, it is determined whether the first confidence level meets or exceeds a first threshold, such as a predetermined COST value in the present embodiment, as described further above. As described above, the present stage, as well as stages 525 and 530, is executed in the present embodiment by the ZAP™ Software, or other suitable algorithm. If the first confidence level fails to meet or exceed the first threshold, such as a COST value of 500 in one embodiment, the possible location marker is not displayed and the method cycles back to stage 520 to continue monitoring for the presence of a possible location marker.


If the first confidence level meets or exceeds the first threshold, however, stage 550 is executed, wherein it is determined whether the first position of the possible location marker is within a first detection zone, such as the first detection zone 140 shown in FIG. 4. This stage is executed in one embodiment by the processor 130 of the system 300, as shown in FIG. 10. If the first position is not within the first detection zone, the possible location marker is not displayed and the method cycles back to stage 520 to continue monitoring for the presence of a possible location marker. If the first position is within the first detection zone, however, stage 560 is executed, wherein the first position of the location marker is displayed, such as on the display 200 shown in FIGS. 8 and 10, for instance.


In one embodiment, stages 520 through 550 are repeated in sequence a predetermined number of times before stage 560 is executed and the location marker is displayed. In one embodiment, stages 520 through 550 are successfully executed eight times, after which the location marker is displayed. Of course, the number of iterations can vary.


Reference is now made to FIG. 12. In one embodiment, the method for displaying the position of a medical device can continue after display of the first position of the location marker at stage 560 such that further advancement of the location marker 40 associated with the medical device, such as the catheter 10 progressing through a vasculature, can be progressively displayed. At stage 570, a second set of detected position data relating to a possible second position of the location marker is obtained.


At stage 575, the possible second position of the location marker is determined. In the present embodiment, the possible second position relates to the first position of the location marker, and as such no best fit guessing by a neural net component of the ZAP™ Software or other suitable algorithm need be performed.


At stage 580, a second confidence level relating to a match between the second set of detected position data and a second set of predicted position data, is assigned. As was the case with stages 525 and 530 of FIG. 11, stages 575 and 580 can be iteratively performed in the present embodiment in order to find a minimum COST value. In other embodiments, a predetermined number of iterations, or no iterations, can be performed.


At stage 590, it is determined whether the second confidence level meets or exceeds a second threshold, such as a predetermined COST value in the present embodiment, as described further above. As has been described, the second threshold in one embodiment is relatively lower, i.e., the COST value is higher, than the first threshold. In the present embodiment, the COST value is 1000, for instance. If the second confidence level fails to meet or exceed the second threshold, the possible location marker is not displayed and the method can cycle back to stage 570 to continue monitoring for further location marker position data.


If the second confidence level meets or exceeds the second threshold, however, stage 600 is executed, wherein it is determined whether the second position of the location marker is within at least one of the first and second detection zones, such as the first detection zone 140 and second detection zone 150 shown in FIG. 4. If not, the possible location marker is not displayed and the method can cycle back to stage 570 to continue monitoring for further location marker position data. If the second position is within the first detection zone and/or the second detection zone, however, stage 610 is executed, wherein the second position of the location marker is displayed.


In one embodiment, stages 570 through 600 are repeated in sequence a predetermined number of times before stage 610 is executed and the location marker is displayed. In another embodiment, no repetitions of the sequence are performed before display at stage 610 is executed.


In one embodiment, stage 580 includes ensuring that the second position of the location marker is within a predetermined distance range from the first position of the location marker within a predetermined amount of time so as to prevent maverick detection of non-location marker targets from being validated as location markers. It is noted that one or more of stages 570-610 of the method 500 can be successively repeated to find and display additional positions of the location marker during advancement of the catheter 10 through the patient's vasculature.


Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A method of depicting a position of a catheter that is within a patient, the method comprising: moving a location marker associated with the catheter along a path in a direction from an entry point toward a destination, wherein the location marker produces a magnetic field;positioning a detector having a first detection zone and a second detection zone such that at least the first detection zone includes a portion of the path, wherein the portion of the path included in the first detection zone is proximal relative to any portion of the path included in the second detection zone;obtaining, via the detector, first measurements of the magnetic field produced by the location marker;determining a first confidence level regarding a first position of the location marker based on the first measurements;displaying an initial representative image of the location marker if the first position is within the first detection zone and the confidence level is above a first threshold value;obtaining, via the detector, second measurements of the magnetic field produced by the location marker;determining a second confidence level regarding a second position of the location marker based on the second measurements; anddisplaying a subsequent representative image of the location marker if the second position is within one or more of the first and second detection zones and the confidence level is above a second threshold value different than the first threshold value.
  • 2. The method of claim 1, wherein the second threshold value is lower than the first threshold value.
  • 3. The method of claim 1, further comprising withholding the initial representative image of the location marker from being displayed if the first position is within the second detection zone and the first confidence level is above the first threshold value.
  • 4. The method of claim 1, further comprising: tracking movement of the location marker after having displayed the initial representative image of the location marker; anddiscontinuing to track movement of the location marker prior to displaying the subsequent representative image.
  • 5. The method of claim 4, wherein the second threshold value is lower than the first threshold value.
  • 6. A system for depicting a position of a catheter, the system comprising: a detector configured to obtain first and second measurements of a magnetic field produced by a location marker associated with the catheter, wherein a first detection zone and a second detection zone are defined relative to the detector;a processor in communication with the detector, wherein the processor is configured to: receive the first measurements from the detector;compare the first measurements with a model of the location marker;provide a first confidence level regarding a first position of the location marker;receive the second measurements from the detector;compare the second measurements with the model of the location marker; andprovide a second confidence level regarding a second position of the location marker; anda display device configured to show an image representative of the location marker, wherein the system is configured to show an initial display of the image only if the first confidence level is above a first threshold value and the first position is within the first detection zone, and wherein the system is configured to show a subsequent display of the image if the second confidence level is above a second threshold value different from the first threshold value and the second position is within one or more of the first and second detection zones.
  • 7. The system of claim 6, wherein the location marker is temporarily or permanently associated with the catheter and includes at least one of the following: a magnetic component; and an electromagnetic field-producing component.
  • 8. The system of claim 6, wherein the location marker is a magnetic component included on a stylet that is removably inserted into a lumen of the catheter.
  • 9. A method for displaying a position of a medical device during placement of the medical device into a patient using a system including a processor, the method comprising: (a) obtaining a first set of detected position data relating to a location marker associated with the medical device;(b) determining a possible first position of the location marker;(c) assigning a first confidence level relating to a match between the first set of detected position data and a first set of predicted position data relating to the possible first position;(d) determining that the first confidence level meets or exceeds a first threshold;(e) determining that the first position of the location marker is within a first detection zone if the first confidence level meets or exceeds the first threshold;(f) displaying the first position of the location marker if the first position of the location marker is within the first detection zone;(g) obtaining a second set of detected position data relating to the location marker;(h) determining a possible second position of the location marker;(i) assigning a second confidence level relating to a match between the second set of detected position data and a second set of predicted position data relating to the possible second position;(j) determining that the second confidence level meets or exceeds a second threshold different from the first threshold;(k) determining that the second position of the location marker is within at least one of the first detection zone and a second detection zone if the second confidence level meets or exceeds the second threshold; and(l) displaying the second position of the location marker if the second position of the location marker is within at least one of the first detection zone and the second detection zone.
  • 10. The method of claim 9, wherein stage (b) further comprises: (b) determining a possible first position of the location marker via a neural net best fit algorithm;and wherein stage (k) further comprises:(k) determining that the second position of the location marker is within at least one of the first detection zone and a second detection zone, the first detection zone at stage (i) including dimensions larger than when the first set of detected position data was obtained at stage (a).
  • 11. The method of claim 9, further comprising calibrating the system before executing stage (a).
  • 12. The method of claim 9, wherein stage (k) further comprises: (k) ensuring that the second position of the location marker is within a predetermined distance range from the first position of the location marker within a predetermined amount of time.
  • 13. The method of claim 9, wherein the location marker includes a magnetic component attached to the medical device, wherein the first position and the second position of the location marker are defined with respect to an X, Y, Z coordinate axis grid including an origin at or proximate to the detector, and wherein a depth of the first detection zone is at least 8 cm.
  • 14. The method of claim 9, wherein at least stages (b) and (c) are repeatedly executed in succession a predetermined number of times before stage (d) is executed.
  • 15. The method of claim 9, wherein a shape of at least one of the first and second detection zones is selected from the list consisting of: square box, rectangular box, triangular volume, spherical, ellipsoid; and paraboloid.
  • 16. A computer program product for implementing a method for displaying a position of a medical device during placement of the medical device into a patient, the computer program product including one or more non-transitory computer-readable media having stored thereon computer executable instructions that, when executed by a processor, cause a computer system to perform the following: (a) obtain a first set of detected position data relating to a location marker associated with the medical device;(b) determine a possible first position of the location marker;(c) assign a first confidence level relating to a match between the first set of detected position data and a first set of predicted position data relating to the possible first position;(d) determine that the first confidence level meets or exceeds a first threshold;(e) determine that the first position of the location marker is within a first detection zone if the first confidence level meets or exceeds the first threshold;(f) display the first position of the location marker if the first position of the location marker is within the first detection zone;(g) obtain a second set of detected position data relating to the location marker;(h) determine a possible second position of the location marker;(i) assign a second confidence level relating to a match between the second set of detected position data and a second set of predicted position data relating to the possible second position;(j) determine that the second confidence level meets or exceeds a second threshold different from the first threshold;(k) determine that the second position of the location marker is within at least one of the first detection zone and a second detection zone if the second confidence level meets or exceeds the second threshold; and(l) display the second position of the location marker if the second position of the location marker is within at least one of the first detection zone and the second detection zone.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Patent Application No. 61/027,710, filed Feb. 11, 2008, and entitled “Systems and Methods for Positioning a Catheter,” which is incorporated herein by reference in its entirety.

US Referenced Citations (1092)
Number Name Date Kind
3133244 Wojtulewicz May 1964 A
3297020 Mathiesen Jan 1967 A
3625200 Muller Dec 1971 A
3674014 Tillander et al. Jul 1972 A
3817241 Grausz Jun 1974 A
3847157 Caillouette et al. Nov 1974 A
3868565 Kuipers Feb 1975 A
3902501 Citron et al. Sep 1975 A
3995623 Blake et al. Dec 1976 A
4003369 Heilman et al. Jan 1977 A
4063561 McKenna Dec 1977 A
4072146 Howes Feb 1978 A
4114601 Abels Sep 1978 A
4149535 Volder Apr 1979 A
4173228 Steenwyk et al. Nov 1979 A
4175566 Millar Nov 1979 A
4181120 Kunii et al. Jan 1980 A
4224949 Scott et al. Sep 1980 A
4244362 Anderson Jan 1981 A
4289139 Enjoji et al. Sep 1981 A
4317078 Weed et al. Feb 1982 A
4327722 Groshong et al. May 1982 A
4362166 Furler et al. Dec 1982 A
4365639 Goldreyer Dec 1982 A
4380237 Newbower Apr 1983 A
4407294 Vilkomerson Oct 1983 A
4429693 Blake et al. Feb 1984 A
4431005 McCormick Feb 1984 A
4431214 Buffington Feb 1984 A
4445501 Bresler May 1984 A
4459854 Richardson et al. Jul 1984 A
4469106 Harui Sep 1984 A
4483343 Beyer et al. Nov 1984 A
4491137 Jingu Jan 1985 A
4565201 Lass Jan 1986 A
4572198 Codrington Feb 1986 A
4577634 Gessman Mar 1986 A
4582067 Silverstein et al. Apr 1986 A
4588394 Schulte et al. May 1986 A
4593687 Gray Jun 1986 A
4595012 Webler et al. Jun 1986 A
4601706 Aillon Jul 1986 A
4608989 Drue Sep 1986 A
4608992 Hakim et al. Sep 1986 A
4619247 Inoue et al. Oct 1986 A
4622644 Hansen Nov 1986 A
4644960 Johans Feb 1987 A
4652820 Maresca Mar 1987 A
4665925 Millar May 1987 A
4667230 Arakawa et al. May 1987 A
4674518 Salo Jun 1987 A
4676249 Arenas et al. Jun 1987 A
4681106 Kensey et al. Jul 1987 A
4681117 Brodman et al. Jul 1987 A
4692148 Kantrowitz et al. Sep 1987 A
4697595 Breyer et al. Oct 1987 A
4700997 Strand Oct 1987 A
4706681 Breyer et al. Nov 1987 A
4710708 Rorden et al. Dec 1987 A
4733669 Segal Mar 1988 A
4737794 Jones Apr 1988 A
4741356 Letzo et al. May 1988 A
4742356 Kuipers May 1988 A
4753247 Kirsner et al. Jun 1988 A
4770185 Silverstein et al. Sep 1988 A
4771788 Millar Sep 1988 A
4781685 Lehmann et al. Nov 1988 A
4784646 Feingold Nov 1988 A
4787070 Suzuki et al. Nov 1988 A
4787396 Pidorenko Nov 1988 A
4793361 DuFault Dec 1988 A
4794930 Machida et al. Jan 1989 A
4796632 Boyd et al. Jan 1989 A
4798588 Aillon Jan 1989 A
4798598 Bonello et al. Jan 1989 A
4809681 Kantrowitz et al. Mar 1989 A
4809713 Grayzel Mar 1989 A
4813729 Speckhart Mar 1989 A
4821731 Martinelli et al. Apr 1989 A
4836214 Sramek Jun 1989 A
4840622 Hardy Jun 1989 A
4849692 Blood Jul 1989 A
4850358 Millar Jul 1989 A
4852580 Wood Aug 1989 A
4856317 Pidorenko et al. Aug 1989 A
4856529 Segal Aug 1989 A
4860757 Lynch et al. Aug 1989 A
4867169 Machida et al. Sep 1989 A
4869263 Segal et al. Sep 1989 A
4869718 Brader Sep 1989 A
4887606 Yock et al. Dec 1989 A
4887615 Taylor Dec 1989 A
4889128 Millar Dec 1989 A
4899756 Sonek Feb 1990 A
4901725 Nappholz et al. Feb 1990 A
4905698 Strohl, Jr. et al. Mar 1990 A
4911173 Terwilliger Mar 1990 A
4911174 Pederson et al. Mar 1990 A
4924870 Wlodarczyk et al. May 1990 A
4943770 Ashley-Rollman et al. Jul 1990 A
4945305 Blood Jul 1990 A
4947852 Nassi et al. Aug 1990 A
4957111 Millar Sep 1990 A
4961433 Christian Oct 1990 A
4966148 Millar Oct 1990 A
4967753 Haase et al. Nov 1990 A
4977886 Takehana et al. Dec 1990 A
4989608 Ratner Feb 1991 A
4995396 Inaba et al. Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
5005592 Cartmell Apr 1991 A
5016173 Kenet et al. May 1991 A
5025799 Wilson Jun 1991 A
5029585 Lieber et al. Jul 1991 A
5040548 Yock Aug 1991 A
5042486 Pfeiler et al. Aug 1991 A
5045071 McCormick et al. Sep 1991 A
5046497 Millar Sep 1991 A
5050607 Bradley et al. Sep 1991 A
5057095 Fabian Oct 1991 A
5058595 Kern Oct 1991 A
5067489 Lind Nov 1991 A
5076278 Vilkomerson et al. Dec 1991 A
5078140 Kwoh Jan 1992 A
5078148 Nassi et al. Jan 1992 A
5078149 Katsumata et al. Jan 1992 A
5078678 Katims Jan 1992 A
5078714 Katims Jan 1992 A
5084022 Claude Jan 1992 A
5092341 Kelen Mar 1992 A
5099845 Besz et al. Mar 1992 A
5099850 Matsui et al. Mar 1992 A
5100387 Ng Mar 1992 A
5105829 Fabian et al. Apr 1992 A
5109862 Kelen et al. May 1992 A
5114401 Stuart et al. May 1992 A
5121750 Katims Jun 1992 A
5134370 Jefferts et al. Jul 1992 A
5144955 O'Hara Sep 1992 A
5158086 Brown et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5161536 Vilkomerson et al. Nov 1992 A
5174295 Christian et al. Dec 1992 A
5184601 Putman Feb 1993 A
5190045 Frazin Mar 1993 A
5202985 Goyal Apr 1993 A
5211165 Dumoulin et al. May 1993 A
5211636 Mische May 1993 A
5214615 Bauer et al. May 1993 A
5217026 Stoy et al. Jun 1993 A
5220924 Frazin Jun 1993 A
5235987 Wolfe Aug 1993 A
5239464 Blair et al. Aug 1993 A
5240004 Walinsky et al. Aug 1993 A
5243995 Maier Sep 1993 A
5246007 Frisbie et al. Sep 1993 A
5247171 Wlodarczyk et al. Sep 1993 A
5251635 Dumoulin et al. Oct 1993 A
5255680 Darrow et al. Oct 1993 A
5257636 White Nov 1993 A
5257979 Jagpal Nov 1993 A
5261409 Dardel Nov 1993 A
5265610 Darrow et al. Nov 1993 A
5265614 Hayakawa et al. Nov 1993 A
5267569 Lienhard Dec 1993 A
5270810 Nishimura Dec 1993 A
5271404 Corl et al. Dec 1993 A
5273025 Sakiyama et al. Dec 1993 A
5273042 Lynch et al. Dec 1993 A
5274551 Corby, Jr. Dec 1993 A
5275053 Wlodarczyk et al. Jan 1994 A
5279129 Ito Jan 1994 A
5279607 Schentag et al. Jan 1994 A
5280786 Wlodarczyk et al. Jan 1994 A
5287331 Schindel et al. Feb 1994 A
5289373 Zarge et al. Feb 1994 A
5292342 Nelson et al. Mar 1994 A
5307072 Jones, Jr. Apr 1994 A
5311871 Yock May 1994 A
5313949 Yock May 1994 A
5318025 Dumoulin et al. Jun 1994 A
5325860 Seward et al. Jul 1994 A
5325873 Hirschi et al. Jul 1994 A
5330496 Alferness Jul 1994 A
5331966 Bennett et al. Jul 1994 A
5333614 Feiring Aug 1994 A
5337678 Grout et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5343865 Gardineer et al. Sep 1994 A
5345940 Seward et al. Sep 1994 A
5348020 Hutson Sep 1994 A
5350352 Buchholtz et al. Sep 1994 A
5357961 Fields et al. Oct 1994 A
5375596 Twiss et al. Dec 1994 A
5376083 Mische Dec 1994 A
5377678 Dumoulin et al. Jan 1995 A
5385053 Wlodarczyk et al. Jan 1995 A
5391199 Ben-Haim Feb 1995 A
5394876 Ma Mar 1995 A
5394877 Orr et al. Mar 1995 A
5395366 D'Andrea et al. Mar 1995 A
5398683 Edwards et al. Mar 1995 A
5398691 Martin et al. Mar 1995 A
5411485 Tennican et al. May 1995 A
5413107 Oakley et al. May 1995 A
5422478 Wlodarczyk et al. Jun 1995 A
5425367 Shapiro et al. Jun 1995 A
5425370 Vilkomerson Jun 1995 A
5425382 Golden et al. Jun 1995 A
5427114 Colliver et al. Jun 1995 A
5429132 Guy et al. Jul 1995 A
5429617 Hammersmark et al. Jul 1995 A
5433729 Adams et al. Jul 1995 A
5437276 Takada et al. Aug 1995 A
5437277 Dumoulin et al. Aug 1995 A
5438873 Wlodarczyk et al. Aug 1995 A
5443066 Dumoulin et al. Aug 1995 A
5443489 Ben-Haim Aug 1995 A
5445150 Dumoulin et al. Aug 1995 A
5450846 Goldreyer Sep 1995 A
5453575 O'Donnell et al. Sep 1995 A
5456256 Schneider Oct 1995 A
5456718 Szymaitis Oct 1995 A
5464016 Nicholas et al. Nov 1995 A
5474065 Meathrel et al. Dec 1995 A
5476090 Kishi Dec 1995 A
5480422 Ben-Haim Jan 1996 A
5487729 Avellanet et al. Jan 1996 A
5490522 Dardel Feb 1996 A
5492538 Johlin, Jr. Feb 1996 A
5494038 Wang et al. Feb 1996 A
5500012 Brucker et al. Mar 1996 A
5505205 Solomon et al. Apr 1996 A
5509822 Negus et al. Apr 1996 A
5513637 Twiss et al. May 1996 A
5515853 Smith et al. May 1996 A
5522878 Montecalvo et al. Jun 1996 A
5526812 Dumoulin et al. Jun 1996 A
5531664 Adachi et al. Jul 1996 A
5540230 Vilkomerson Jul 1996 A
5540681 Strul et al. Jul 1996 A
5542938 Avellanet et al. Aug 1996 A
5546949 Frazin et al. Aug 1996 A
5546951 Ben-Haim Aug 1996 A
5558091 Acker et al. Sep 1996 A
5568809 Ben-haim Oct 1996 A
5570671 Hickey Nov 1996 A
5575291 Hayakawa et al. Nov 1996 A
5588442 Scovil et al. Dec 1996 A
5592939 Martinelli Jan 1997 A
5598846 Peszynski Feb 1997 A
5599299 Weaver et al. Feb 1997 A
5600330 Blood Feb 1997 A
5610967 Moorman et al. Mar 1997 A
5617866 Marian, Jr. Apr 1997 A
5622169 Golden et al. Apr 1997 A
5622170 Schulz Apr 1997 A
5623931 Wung et al. Apr 1997 A
5624430 Eton et al. Apr 1997 A
5626554 Ryaby et al. May 1997 A
5626870 Monshipouri et al. May 1997 A
5644612 Moorman et al. Jul 1997 A
5645065 Shapiro et al. Jul 1997 A
5651047 Moorman et al. Jul 1997 A
5654864 Ritter et al. Aug 1997 A
5662115 Torp et al. Sep 1997 A
5665477 Meathrel et al. Sep 1997 A
5666473 Wallace Sep 1997 A
5666958 Rothenberg et al. Sep 1997 A
5669383 Johnson Sep 1997 A
5669388 Vilkomerson Sep 1997 A
5676159 Navis Oct 1997 A
5676673 Ferre et al. Oct 1997 A
5691898 Rosenberg et al. Nov 1997 A
5694945 Ben-Haim Dec 1997 A
5695479 Jagpal Dec 1997 A
5697377 Wittkampf Dec 1997 A
5699801 Atalar et al. Dec 1997 A
5700889 Blair Dec 1997 A
5713362 Vilkomerson Feb 1998 A
5713363 Seward et al. Feb 1998 A
5713946 Ben-Haim Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5722412 Pflugrath et al. Mar 1998 A
5727550 Montecalvo Mar 1998 A
5727552 Ryan Mar 1998 A
5727553 Saad Mar 1998 A
5729055 Manning Mar 1998 A
5729129 Acker Mar 1998 A
5729584 Moorman et al. Mar 1998 A
5730129 Darrow et al. Mar 1998 A
5731996 Gilbert Mar 1998 A
5733323 Buck et al. Mar 1998 A
5738096 Ben-Haim Apr 1998 A
5740808 Panescu et al. Apr 1998 A
5742394 Hansen Apr 1998 A
5744953 Hansen Apr 1998 A
5748767 Raab May 1998 A
5749835 Glantz May 1998 A
5749938 Coombs May 1998 A
5751785 Moorman et al. May 1998 A
5752513 Acker et al. May 1998 A
5758650 Miller Jun 1998 A
5762064 Polvani Jun 1998 A
5767669 Hansen et al. Jun 1998 A
5767960 Orman et al. Jun 1998 A
5769786 Wiegel Jun 1998 A
5769843 Abela et al. Jun 1998 A
5769881 Schroeppel et al. Jun 1998 A
5771896 Sliwa, Jr. et al. Jun 1998 A
5775322 Silverstein et al. Jul 1998 A
5775332 Goldman Jul 1998 A
5779638 Vesely et al. Jul 1998 A
5782767 Pretlow, III Jul 1998 A
5785657 Breyer et al. Jul 1998 A
5792055 McKinnon et al. Aug 1998 A
5795297 Daigle Aug 1998 A
5795298 Vesely et al. Aug 1998 A
5795632 Buchalter Aug 1998 A
5797849 Vesely et al. Aug 1998 A
5800352 Ferre et al. Sep 1998 A
5800410 Gawreluk Sep 1998 A
5800497 Bakels et al. Sep 1998 A
5803089 Ferre et al. Sep 1998 A
5810733 Van Creveld et al. Sep 1998 A
5817022 Vesely Oct 1998 A
5817024 Ogle et al. Oct 1998 A
5820549 Marian, Jr. Oct 1998 A
5824031 Cookston et al. Oct 1998 A
5829444 Ferre et al. Nov 1998 A
5830145 Tenhoff Nov 1998 A
5831260 Hansen Nov 1998 A
5833608 Acker Nov 1998 A
5833622 Meathrel et al. Nov 1998 A
5835561 Moorman et al. Nov 1998 A
5836882 Frazin Nov 1998 A
5836990 Li Nov 1998 A
5840024 Taniguchi et al. Nov 1998 A
5840025 Ben-Haim Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5840031 Crowley Nov 1998 A
5842986 Avrin et al. Dec 1998 A
5843076 Webster, Jr. et al. Dec 1998 A
5843153 Johnston et al. Dec 1998 A
5844140 Seale Dec 1998 A
5846198 Killmann Dec 1998 A
5855553 Tajima et al. Jan 1999 A
5859893 Moorman et al. Jan 1999 A
5865748 Co et al. Feb 1999 A
5868673 Vesely Feb 1999 A
5873822 Ferre et al. Feb 1999 A
5879297 Haynor et al. Mar 1999 A
5893363 Little et al. Apr 1999 A
5897495 Aida et al. Apr 1999 A
5899860 Pfeiffer et al. May 1999 A
5902238 Golden et al. May 1999 A
5907487 Rosenberg et al. May 1999 A
5908385 Chechelski et al. Jun 1999 A
5910113 Pruter Jun 1999 A
5910120 Kim et al. Jun 1999 A
5913820 Bladen et al. Jun 1999 A
5913830 Miles Jun 1999 A
5919141 Money et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5928145 Ocali et al. Jul 1999 A
5929607 Rosenberg et al. Jul 1999 A
5931788 Keen et al. Aug 1999 A
5931818 Werp et al. Aug 1999 A
5941858 Johnson Aug 1999 A
5941889 Cermak Aug 1999 A
5941904 Johnston et al. Aug 1999 A
5944022 Nardella et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5953683 Hansen et al. Sep 1999 A
5957857 Hartley Sep 1999 A
5961923 Nova et al. Oct 1999 A
5967978 Littmann et al. Oct 1999 A
5967980 Ferre et al. Oct 1999 A
5967991 Gardineer et al. Oct 1999 A
5969722 Palm Oct 1999 A
5978705 KenKnight et al. Nov 1999 A
5983126 Wittkampf Nov 1999 A
5984908 Davis et al. Nov 1999 A
5991693 Zalewski Nov 1999 A
5997473 Taniguchi et al. Dec 1999 A
5997481 Adams et al. Dec 1999 A
6006123 Nguyen et al. Dec 1999 A
6011988 Lynch et al. Jan 2000 A
6014473 Hossack et al. Jan 2000 A
6014580 Blume et al. Jan 2000 A
6015414 Werp et al. Jan 2000 A
6017496 Nova et al. Jan 2000 A
6019724 Gronningsaeter et al. Feb 2000 A
6019725 Vesely et al. Feb 2000 A
6023638 Swanson Feb 2000 A
6026312 Shemwell et al. Feb 2000 A
6031765 Lee et al. Feb 2000 A
6032070 Flock et al. Feb 2000 A
6039694 Larson et al. Mar 2000 A
6050718 Schena et al. Apr 2000 A
6052610 Koch Apr 2000 A
6052618 Dahlke et al. Apr 2000 A
D424693 Pruter May 2000 S
6059718 Taniguchi et al. May 2000 A
6064905 Webster, Jr. et al. May 2000 A
6066094 Ben-Haim May 2000 A
6068599 Saito et al. May 2000 A
6073043 Schneider Jun 2000 A
6074367 Hubbell Jun 2000 A
6075442 Welch Jun 2000 A
6076007 England et al. Jun 2000 A
6082366 Andra et al. Jul 2000 A
6083170 Ben-Haim Jul 2000 A
6099524 Lipson et al. Aug 2000 A
6100026 Nova et al. Aug 2000 A
6102044 Naidyhorski Aug 2000 A
6107699 Swanson Aug 2000 A
6112111 Glantz Aug 2000 A
6113504 Kuesters Sep 2000 A
6115624 Lewis et al. Sep 2000 A
6120445 Grunwald Sep 2000 A
6128174 Ritter et al. Oct 2000 A
6129668 Haynor et al. Oct 2000 A
6132378 Marino Oct 2000 A
6132379 Patacsil et al. Oct 2000 A
6135961 Pflugrath et al. Oct 2000 A
6136274 Nova et al. Oct 2000 A
6138681 Chen et al. Oct 2000 A
6139496 Chen et al. Oct 2000 A
6139502 Fredriksen Oct 2000 A
6144300 Dames et al. Nov 2000 A
6148823 Hastings Nov 2000 A
6152933 Werp et al. Nov 2000 A
6157853 Blume et al. Dec 2000 A
6165144 Talish et al. Dec 2000 A
6166496 Lys et al. Dec 2000 A
6166806 Tjin Dec 2000 A
6167765 Weitzel Jan 2001 B1
6172499 Ashe Jan 2001 B1
6173199 Gabriel Jan 2001 B1
6173715 Sinanan et al. Jan 2001 B1
6175756 Ferre et al. Jan 2001 B1
6176829 Vilkomerson Jan 2001 B1
6193743 Brayton et al. Feb 2001 B1
6200305 Berthiaume et al. Mar 2001 B1
6203499 Imling et al. Mar 2001 B1
6208884 Kumar et al. Mar 2001 B1
6211626 Lys et al. Apr 2001 B1
6211666 Acker Apr 2001 B1
6212426 Swanson Apr 2001 B1
6216027 Willis et al. Apr 2001 B1
6216028 Haynor et al. Apr 2001 B1
6216029 Paltieli Apr 2001 B1
6223087 Williams Apr 2001 B1
6226547 Lockhart et al. May 2001 B1
6230046 Crane et al. May 2001 B1
6233476 Strommer et al. May 2001 B1
6238344 Gamelsky et al. May 2001 B1
6241673 Williams Jun 2001 B1
6246231 Ashe Jun 2001 B1
6246898 Vesely et al. Jun 2001 B1
6248072 Murkin Jun 2001 B1
6248074 Ohno et al. Jun 2001 B1
6248075 McGee et al. Jun 2001 B1
6253770 Acker et al. Jul 2001 B1
6259941 Chia et al. Jul 2001 B1
6261231 Damphousse et al. Jul 2001 B1
6263230 Haynor et al. Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6266551 Osadchy et al. Jul 2001 B1
6266552 Slettenmark Jul 2001 B1
6266563 KenKnight et al. Jul 2001 B1
6271833 Rosenberg et al. Aug 2001 B1
6272371 Shlomo Aug 2001 B1
6272374 Flock et al. Aug 2001 B1
6275258 Chim Aug 2001 B1
6275724 Dickinson et al. Aug 2001 B1
6277077 Brisken et al. Aug 2001 B1
6284459 Nova et al. Sep 2001 B1
6285898 Ben-Haim Sep 2001 B1
6288704 Flack et al. Sep 2001 B1
6292678 Hall et al. Sep 2001 B1
6292680 Somogyi et al. Sep 2001 B1
6292901 Lys et al. Sep 2001 B1
6293955 Houser et al. Sep 2001 B1
6296604 Garibaldi et al. Oct 2001 B1
6298261 Rex Oct 2001 B1
6304768 Blume et al. Oct 2001 B1
6306097 Park et al. Oct 2001 B1
6311082 Creighton, IV et al. Oct 2001 B1
6315709 Garibaldi et al. Nov 2001 B1
6315727 Coleman et al. Nov 2001 B1
6319668 Nova et al. Nov 2001 B1
6323769 Dames et al. Nov 2001 B1
6323770 Dames et al. Nov 2001 B1
6324416 Seibert Nov 2001 B1
6325540 Lounsberry et al. Dec 2001 B1
6325762 Tjin Dec 2001 B1
6329139 Nova et al. Dec 2001 B1
6329916 Dames et al. Dec 2001 B1
6330467 Creighton, IV et al. Dec 2001 B1
6332089 Acker et al. Dec 2001 B1
6332874 Eliasen et al. Dec 2001 B1
6340588 Nova et al. Jan 2002 B1
6340868 Lys et al. Jan 2002 B1
6341231 Ferre et al. Jan 2002 B1
6346081 Vilkomerson Feb 2002 B1
6348911 Rosenberg et al. Feb 2002 B1
6350160 Feuersanger et al. Feb 2002 B1
6352363 Munger et al. Mar 2002 B1
6355026 Mick Mar 2002 B1
6361499 Bates et al. Mar 2002 B1
6364823 Garibaldi et al. Apr 2002 B1
6364839 Little et al. Apr 2002 B1
6366804 Mejia Apr 2002 B1
6368285 Osadchy et al. Apr 2002 B1
6370411 Osadchy et al. Apr 2002 B1
6373240 Govari Apr 2002 B1
6373388 Dames et al. Apr 2002 B1
6374134 Bladen et al. Apr 2002 B1
6374670 Spelman et al. Apr 2002 B1
6375606 Garibaldi et al. Apr 2002 B1
6375639 Duplessie et al. Apr 2002 B1
6377857 Brayton et al. Apr 2002 B1
6379302 Kessman et al. Apr 2002 B1
6379303 Seitz et al. Apr 2002 B1
6379307 Filly et al. Apr 2002 B1
6381485 Hunter et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6385476 Osadchy et al. May 2002 B1
6398736 Seward Jun 2002 B1
6401723 Garibaldi et al. Jun 2002 B1
6406442 McFann et al. Jun 2002 B1
6412978 Watanabe et al. Jul 2002 B1
6412980 Lounsberry et al. Jul 2002 B1
6417839 Odell Jul 2002 B1
6418332 Mastrototaro et al. Jul 2002 B1
6418335 Avrin et al. Jul 2002 B2
6423002 Hossack Jul 2002 B1
6423050 Twardowski Jul 2002 B1
6427079 Schneider et al. Jul 2002 B1
6428551 Hall et al. Aug 2002 B1
6430315 Makram-Ebeid Aug 2002 B1
6432069 Godo et al. Aug 2002 B1
6438411 Guttman et al. Aug 2002 B1
6439573 Sklar Aug 2002 B1
6442416 Schultz Aug 2002 B1
6445943 Ferre et al. Sep 2002 B1
6459919 Lys et al. Oct 2002 B1
6463121 Milnes Oct 2002 B1
6473167 Odell Oct 2002 B1
6474341 Hunter et al. Nov 2002 B1
6475152 Kelly, Jr. et al. Nov 2002 B1
6475223 Werp et al. Nov 2002 B1
6477402 Lynch et al. Nov 2002 B1
6484118 Govari et al. Nov 2002 B1
6487916 Gomm et al. Dec 2002 B1
6491671 Larson, III et al. Dec 2002 B1
6493573 Martinelli et al. Dec 2002 B1
6496715 Lee et al. Dec 2002 B1
6498944 Ben-Haim et al. Dec 2002 B1
6500141 Irion et al. Dec 2002 B1
6505062 Ritter et al. Jan 2003 B1
6507751 Blume et al. Jan 2003 B2
6508802 Rosengart et al. Jan 2003 B1
6512958 Swoyer et al. Jan 2003 B1
6514249 Maguire et al. Feb 2003 B1
6515657 Zanelli Feb 2003 B1
6516212 Bladen et al. Feb 2003 B1
6516231 Flammang Feb 2003 B1
6516807 Panescu et al. Feb 2003 B1
6517520 Chang et al. Feb 2003 B2
6522906 Salisbury, Jr. et al. Feb 2003 B1
6522907 Bladen et al. Feb 2003 B1
6522909 Garibaldi et al. Feb 2003 B1
6524303 Garibaldi Feb 2003 B1
6528954 Lys et al. Mar 2003 B1
6528991 Ashe Mar 2003 B2
6529761 Creighton, IV et al. Mar 2003 B2
6534982 Jakab Mar 2003 B1
6535625 Chang et al. Mar 2003 B1
6537192 Elliott et al. Mar 2003 B1
6537196 Creighton, IV et al. Mar 2003 B1
6538634 Chui et al. Mar 2003 B1
6540699 Smith et al. Apr 2003 B1
6542766 Hall et al. Apr 2003 B2
6544251 Crawford Apr 2003 B1
6546270 Goldin et al. Apr 2003 B1
6546279 Bova et al. Apr 2003 B1
6546787 Schiller et al. Apr 2003 B1
6552841 Lasser et al. Apr 2003 B1
6556858 Zeman Apr 2003 B1
6562019 Sell May 2003 B1
6564087 Pitris et al. May 2003 B1
6569101 Quistgaard et al. May 2003 B2
6571004 Florent et al. May 2003 B1
6574518 Lounsberry et al. Jun 2003 B1
6575908 Barnes et al. Jun 2003 B2
6577080 Lys et al. Jun 2003 B2
6577896 Werner et al. Jun 2003 B2
6584343 Ransbury et al. Jun 2003 B1
6593754 Steber et al. Jul 2003 B1
6593884 Gilboa et al. Jul 2003 B1
6597943 Taha et al. Jul 2003 B2
6599249 Nordgren et al. Jul 2003 B1
6607488 Jackson et al. Aug 2003 B1
6610058 Flores Aug 2003 B2
6611141 Schulz et al. Aug 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6615155 Gilboa Sep 2003 B2
6618612 Acker et al. Sep 2003 B1
6626832 Paltieli et al. Sep 2003 B1
6626834 Dunne et al. Sep 2003 B2
6626902 Kucharczyk et al. Sep 2003 B1
6630879 Creighton, IV et al. Oct 2003 B1
6635027 Cragg et al. Oct 2003 B1
6645148 Nguyen-Dinh et al. Nov 2003 B2
6648875 Simpson et al. Nov 2003 B2
6649914 Moorman et al. Nov 2003 B1
6652506 Bowe et al. Nov 2003 B2
6662034 Segner et al. Dec 2003 B2
6672308 Gaspari Jan 2004 B1
6677752 Creighton, IV et al. Jan 2004 B1
6679857 Bastia et al. Jan 2004 B1
6684176 Willins et al. Jan 2004 B2
6685644 Seo et al. Feb 2004 B2
6687531 Ferre et al. Feb 2004 B1
6689119 Di Caprio et al. Feb 2004 B1
6690963 Ben-Haim et al. Feb 2004 B2
6690964 Bieger et al. Feb 2004 B2
6690968 Mejia Feb 2004 B2
6694167 Ferre et al. Feb 2004 B1
6695786 Wang et al. Feb 2004 B2
6701179 Martinelli et al. Mar 2004 B1
6701918 Fariss et al. Mar 2004 B2
6702804 Ritter et al. Mar 2004 B1
6704590 Haldeman Mar 2004 B2
6709390 Marie Pop Mar 2004 B1
6711429 Gilboa et al. Mar 2004 B1
6711431 Sarin et al. Mar 2004 B2
6719699 Smith Apr 2004 B2
6719724 Walker et al. Apr 2004 B1
6719756 Muntermann Apr 2004 B1
6720745 Lys et al. Apr 2004 B2
6733511 Hall et al. May 2004 B2
6736782 Pfeiffer et al. May 2004 B2
6738656 Ferre et al. May 2004 B1
6740103 Hall et al. May 2004 B2
6743177 Ito et al. Jun 2004 B2
6754596 Ashe Jun 2004 B2
6755789 Stringer et al. Jun 2004 B2
6755816 Ritter et al. Jun 2004 B2
6757557 Bladen et al. Jun 2004 B1
6763261 Casscells, III et al. Jul 2004 B2
6764449 Lee et al. Jul 2004 B2
6768496 Bieger et al. Jul 2004 B2
6772001 Maschke et al. Aug 2004 B2
6774624 Anderson et al. Aug 2004 B2
6783536 Vilsmeier et al. Aug 2004 B2
6784660 Ashe Aug 2004 B2
6785571 Glossop et al. Aug 2004 B2
6786219 Garibaldi et al. Sep 2004 B2
6788967 Ben-Haim et al. Sep 2004 B2
6794667 Noshi Sep 2004 B2
6799066 Steines et al. Sep 2004 B2
6815651 Odell Nov 2004 B2
6816266 Varshneya et al. Nov 2004 B2
6817364 Garibaldi Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6844713 Steber et al. Jan 2005 B2
6845142 Ohishi Jan 2005 B2
6856823 Ashe Feb 2005 B2
6860422 Hull et al. Mar 2005 B2
6862467 Moore et al. Mar 2005 B2
6869390 Elliott et al. Mar 2005 B2
6875179 Ferguson et al. Apr 2005 B2
6879160 Jakab Apr 2005 B2
6889091 Hine et al. May 2005 B2
6895268 Rahn et al. May 2005 B1
6902528 Garibaldi et al. Jun 2005 B1
6908433 Pruter Jun 2005 B1
6911026 Hall et al. Jun 2005 B1
6923782 O'Mahony et al. Aug 2005 B2
6926673 Roberts et al. Aug 2005 B2
6934575 Ferre et al. Aug 2005 B2
6936010 Fang et al. Aug 2005 B2
6940379 Creighton Sep 2005 B2
6941166 MacAdam et al. Sep 2005 B2
6947788 Gilboa et al. Sep 2005 B2
6950689 Willis et al. Sep 2005 B1
6953754 Machida et al. Oct 2005 B2
6958677 Carter Oct 2005 B1
6959214 Pape et al. Oct 2005 B2
6962566 Quistgaard et al. Nov 2005 B2
6968846 Viswanathan Nov 2005 B2
6975197 Creighton, IV Dec 2005 B2
6976962 Bullis Dec 2005 B2
6976987 Flores Dec 2005 B2
6980843 Eng et al. Dec 2005 B2
6980852 Jersey-Willuhn et al. Dec 2005 B2
6980921 Anderson et al. Dec 2005 B2
6986739 Warren et al. Jan 2006 B2
6999821 Jenney et al. Feb 2006 B2
7001355 Nunomura et al. Feb 2006 B2
7008418 Hall et al. Mar 2006 B2
7010338 Ritter et al. Mar 2006 B2
7015393 Weiner et al. Mar 2006 B2
7017584 Garibaldi et al. Mar 2006 B2
7019610 Creighton, IV et al. Mar 2006 B2
7020512 Ritter et al. Mar 2006 B2
7022075 Grunwald et al. Apr 2006 B2
7022082 Sonek Apr 2006 B2
7026927 Wright et al. Apr 2006 B2
7027634 Odell Apr 2006 B2
7028387 Huynh et al. Apr 2006 B1
7029446 Wendelken et al. Apr 2006 B2
7033603 Nelson et al. Apr 2006 B2
7038398 Lys et al. May 2006 B1
7038657 Rosenberg et al. May 2006 B2
7043293 Baura May 2006 B1
7054228 Hickling May 2006 B1
7066914 Andersen Jun 2006 B2
7066924 Garibaldi et al. Jun 2006 B1
7070565 Vaezy et al. Jul 2006 B2
7072704 Bucholz Jul 2006 B2
7082325 Hashimshony et al. Jul 2006 B2
7090639 Govari Aug 2006 B2
7096148 Anderson et al. Aug 2006 B2
7096870 Lamprich et al. Aug 2006 B2
7098907 Houston et al. Aug 2006 B2
7103205 Wang et al. Sep 2006 B2
7104980 Laherty et al. Sep 2006 B1
7106043 Da Silva et al. Sep 2006 B1
7106431 Odell Sep 2006 B2
7106479 Roy et al. Sep 2006 B2
7107105 Bjorklund et al. Sep 2006 B2
7132804 Lys et al. Nov 2006 B2
7137976 Ritter et al. Nov 2006 B2
7141812 Appleby et al. Nov 2006 B2
7142905 Slayton et al. Nov 2006 B2
7148970 de Boer Dec 2006 B2
7153291 Bierman Dec 2006 B2
7161453 Creighton, IV Jan 2007 B2
7162291 Nachaliel Jan 2007 B1
7167738 Schweikard et al. Jan 2007 B2
7169107 Jersey-Willuhn et al. Jan 2007 B2
7174201 Govari et al. Feb 2007 B2
7175646 Brenneman et al. Feb 2007 B2
7180252 Lys et al. Feb 2007 B2
7184820 Jersey-Willuhn et al. Feb 2007 B2
7189198 Harburn et al. Mar 2007 B2
7190819 Viswanathan Mar 2007 B2
7194295 Vilsmeier Mar 2007 B2
7204798 Zdeblick et al. Apr 2007 B2
7206064 Rogers et al. Apr 2007 B2
7207941 Sharf Apr 2007 B2
7211082 Hall et al. May 2007 B2
7214191 Stringer et al. May 2007 B2
7215326 Rosenberg May 2007 B2
7221104 Lys et al. May 2007 B2
7223256 Bierman May 2007 B2
7229400 Elliott et al. Jun 2007 B2
7231243 Tearney et al. Jun 2007 B2
7236157 Schena et al. Jun 2007 B2
7236816 Kumar et al. Jun 2007 B2
7237313 Skujins et al. Jul 2007 B2
7241267 Furia Jul 2007 B2
7244234 Ridley et al. Jul 2007 B2
7248032 Hular et al. Jul 2007 B1
7248914 Hastings et al. Jul 2007 B2
7264584 Ritter et al. Sep 2007 B2
7270662 Visram et al. Sep 2007 B2
7276044 Ferry et al. Oct 2007 B2
7286034 Creighton Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297140 Orlu et al. Nov 2007 B2
7308296 Lys et al. Dec 2007 B2
7310150 Guillermo et al. Dec 2007 B2
7321228 Govari Jan 2008 B2
7342058 Peppmoller et al. Mar 2008 B2
7355716 de Boer et al. Apr 2008 B2
7360427 Drinkwater et al. Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7366562 Dukesherer et al. Apr 2008 B2
7366563 Kleen et al. Apr 2008 B2
7373271 Schneider May 2008 B1
7382949 Bouma et al. Jun 2008 B2
7418169 Tearney et al. Aug 2008 B2
7447408 Bouma et al. Nov 2008 B2
7452358 Stern et al. Nov 2008 B2
7479141 Kleen et al. Jan 2009 B2
7534223 Boutilette et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7547282 Lo et al. Jun 2009 B2
7551293 Yelin et al. Jun 2009 B2
7599730 Hunter et al. Oct 2009 B2
7635336 Pruter Dec 2009 B1
7637163 Fetzer et al. Dec 2009 B2
7640053 Verin Dec 2009 B2
7651469 Osborne et al. Jan 2010 B2
7652080 Peppmoller et al. Jan 2010 B2
7665893 Buchalter Feb 2010 B2
7668583 Fegert et al. Feb 2010 B2
7699782 Angelsen et al. Apr 2010 B2
7727192 Tokumoto et al. Jun 2010 B2
7751865 Jascob et al. Jul 2010 B2
7766839 Rogers et al. Aug 2010 B2
7774051 Voth Aug 2010 B2
7794407 Rothenberg Sep 2010 B2
7798970 Lo et al. Sep 2010 B2
7819810 Stringer et al. Oct 2010 B2
7850613 Stribling Dec 2010 B2
7909815 Whitmore, III et al. Mar 2011 B2
7931596 Rachlin et al. Apr 2011 B2
7976469 Bonde et al. Jul 2011 B2
8118743 Park et al. Feb 2012 B2
20020019447 Renn et al. Feb 2002 A1
20020022777 Crieghton et al. Feb 2002 A1
20020032391 McFann et al. Mar 2002 A1
20020055680 Miele et al. May 2002 A1
20020082559 Chang et al. Jun 2002 A1
20020113555 Lys et al. Aug 2002 A1
20020123679 Dominguez Sep 2002 A1
20020128554 Seward Sep 2002 A1
20020133079 Sandhu Sep 2002 A1
20020156363 Hunter et al. Oct 2002 A1
20020156376 Wang et al. Oct 2002 A1
20020165448 Ben-Haim et al. Nov 2002 A1
20020165534 Hayzelden et al. Nov 2002 A1
20020198568 Hafer et al. Dec 2002 A1
20030009132 Schwartz et al. Jan 2003 A1
20030011359 Ashe Jan 2003 A1
20030013966 Barnes et al. Jan 2003 A1
20030036696 Willis et al. Feb 2003 A1
20030040671 Somogyi et al. Feb 2003 A1
20030072805 Miyazawa et al. Apr 2003 A1
20030076281 Morgan et al. Apr 2003 A1
20030083698 Whitehurst et al. May 2003 A1
20030088195 Vardi et al. May 2003 A1
20030100849 Jang May 2003 A1
20030114742 Lewkowicz et al. Jun 2003 A1
20030114777 Griffin et al. Jun 2003 A1
20030120150 Govari Jun 2003 A1
20030120154 Sauer et al. Jun 2003 A1
20030139661 Kimchy et al. Jul 2003 A1
20030149328 Elliott et al. Aug 2003 A1
20030152290 Odell Aug 2003 A1
20030160721 Gilboa et al. Aug 2003 A1
20030163037 Bladen et al. Aug 2003 A1
20030171691 Casscells et al. Sep 2003 A1
20030173953 Ashe Sep 2003 A1
20030184544 Prudent Oct 2003 A1
20030191392 Haldeman Oct 2003 A1
20030191460 Hobbs et al. Oct 2003 A1
20030195420 Mendlein et al. Oct 2003 A1
20030199746 Fuimaono et al. Oct 2003 A1
20030208142 Boudewijn et al. Nov 2003 A1
20030216639 Gilboa et al. Nov 2003 A1
20030220557 Cleary et al. Nov 2003 A1
20030220578 Ho et al. Nov 2003 A1
20030229298 Iwami et al. Dec 2003 A1
20030233042 Ashe Dec 2003 A1
20040015070 Liang et al. Jan 2004 A1
20040024301 Hockett et al. Feb 2004 A1
20040030319 Korkor et al. Feb 2004 A1
20040054278 Kimchy et al. Mar 2004 A1
20040082916 Jenkins Apr 2004 A1
20040087877 Besz et al. May 2004 A1
20040088136 Ashe May 2004 A1
20040097803 Panescu May 2004 A1
20040097804 Sobe May 2004 A1
20040097805 Verard et al. May 2004 A1
20040097806 Hunter et al. May 2004 A1
20040116809 Chow et al. Jun 2004 A1
20040127805 MacAdam et al. Jul 2004 A1
20040131998 Marom et al. Jul 2004 A1
20040133111 Szczech et al. Jul 2004 A1
20040133130 Ferry et al. Jul 2004 A1
20040135069 Odell Jul 2004 A1
20040138564 Hwang et al. Jul 2004 A1
20040138570 Nita et al. Jul 2004 A1
20040147837 Macaulay et al. Jul 2004 A1
20040150963 Holmberg et al. Aug 2004 A1
20040152972 Hunter Aug 2004 A1
20040155609 Lys et al. Aug 2004 A1
20040158140 Fuimaono et al. Aug 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040176688 Haldeman Sep 2004 A1
20040186461 DiMatteo Sep 2004 A1
20040199069 Connelly et al. Oct 2004 A1
20040210289 Wang et al. Oct 2004 A1
20040230271 Wang et al. Nov 2004 A1
20040234453 Smith Nov 2004 A1
20040253365 Warren et al. Dec 2004 A1
20040254470 Drinkwater et al. Dec 2004 A1
20040260174 Keene Dec 2004 A1
20040267086 Anstadt et al. Dec 2004 A1
20050004450 Ben-Haim et al. Jan 2005 A1
20050021019 Hashimshony et al. Jan 2005 A1
20050033150 Takahashi et al. Feb 2005 A1
20050038355 Gellman et al. Feb 2005 A1
20050049486 Urquhart et al. Mar 2005 A1
20050049510 Haldeman et al. Mar 2005 A1
20050063194 Lys et al. Mar 2005 A1
20050070788 Wilson et al. Mar 2005 A1
20050075561 Golden Apr 2005 A1
20050085716 Hamm et al. Apr 2005 A1
20050085718 Shahidi Apr 2005 A1
20050085720 Jascob et al. Apr 2005 A1
20050101868 Ridley et al. May 2005 A1
20050101869 Burba et al. May 2005 A1
20050105081 Odell May 2005 A1
20050105101 Duling et al. May 2005 A1
20050112135 Cormier et al. May 2005 A1
20050113669 Helfer et al. May 2005 A1
20050113676 Weiner et al. May 2005 A1
20050113700 Yanagihara et al. May 2005 A1
20050113873 Weiner et al. May 2005 A1
20050113874 Connelly et al. May 2005 A1
20050113876 Weiner et al. May 2005 A1
20050149002 Wang et al. Jul 2005 A1
20050151489 Lys et al. Jul 2005 A1
20050154308 Quistgaard et al. Jul 2005 A1
20050159644 Takano Jul 2005 A1
20050159790 Shalev Jul 2005 A1
20050165301 Smith et al. Jul 2005 A1
20050165313 Byron et al. Jul 2005 A1
20050175665 Hunter et al. Aug 2005 A1
20050175703 Hunter et al. Aug 2005 A1
20050178395 Hunter et al. Aug 2005 A1
20050178396 Hunter et al. Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050203368 Verin Sep 2005 A1
20050203396 Angelsen et al. Sep 2005 A1
20050205081 Barker et al. Sep 2005 A1
20050215901 Anderson et al. Sep 2005 A1
20050215945 Harris et al. Sep 2005 A1
20050222532 Bertolero et al. Oct 2005 A1
20050240102 Rachlin et al. Oct 2005 A1
20050256398 Hastings et al. Nov 2005 A1
20050256541 Stypulkowski Nov 2005 A1
20060015003 Moaddes et al. Jan 2006 A1
20060025677 Verard et al. Feb 2006 A1
20060031765 Roderick et al. Feb 2006 A1
20060058633 Hoshino et al. Mar 2006 A1
20060068074 Stefandl Mar 2006 A1
20060084867 Tremblay et al. Apr 2006 A1
20060116571 Maschke et al. Jun 2006 A1
20060116578 Grunwald et al. Jun 2006 A1
20060149134 Soper et al. Jul 2006 A1
20060173329 Irioka et al. Aug 2006 A1
20060173407 Shaughnessy et al. Aug 2006 A1
20060176242 Jaramaz et al. Aug 2006 A1
20060184074 Vaezy et al. Aug 2006 A1
20060206037 Braxton Sep 2006 A1
20060211944 Mauge et al. Sep 2006 A1
20060224188 Libbus et al. Oct 2006 A1
20060247746 Danek et al. Nov 2006 A1
20060276867 Viswanathan Dec 2006 A1
20070010753 MacAdam Jan 2007 A1
20070016007 Govari et al. Jan 2007 A1
20070016013 Camus Jan 2007 A1
20070016068 Grunwald et al. Jan 2007 A1
20070016069 Grunwald et al. Jan 2007 A1
20070016070 Grunwald et al. Jan 2007 A1
20070016072 Grunwald et al. Jan 2007 A1
20070049822 Bunce et al. Mar 2007 A1
20070049846 Bown et al. Mar 2007 A1
20070055141 Kruger et al. Mar 2007 A1
20070055142 Webler Mar 2007 A1
20070060992 Pappone Mar 2007 A1
20070062544 Rauk Bergstrom et al. Mar 2007 A1
20070073155 Park et al. Mar 2007 A1
20070087038 Richardson et al. Apr 2007 A1
20070093710 Maschke Apr 2007 A1
20070100285 Griffin et al. May 2007 A1
20070112282 Skujins et al. May 2007 A1
20070123805 Shireman et al. May 2007 A1
20070129770 Younis Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070135886 Maschke Jun 2007 A1
20070156205 Larson et al. Jul 2007 A1
20070167738 Timinger et al. Jul 2007 A1
20070167801 Webler et al. Jul 2007 A1
20070167997 Forsberg et al. Jul 2007 A1
20070197905 Timinger et al. Aug 2007 A1
20070208255 Ridley et al. Sep 2007 A1
20070225589 Viswanathan Sep 2007 A1
20070225610 Mickley et al. Sep 2007 A1
20070232882 Glossop et al. Oct 2007 A1
20070238984 Maschke et al. Oct 2007 A1
20070239018 Fetzer et al. Oct 2007 A1
20070244413 Biggins Oct 2007 A1
20070247454 Rahn et al. Oct 2007 A1
20070249911 Simon Oct 2007 A1
20070265526 Govari et al. Nov 2007 A1
20070280974 Son et al. Dec 2007 A1
20070282196 Birk et al. Dec 2007 A1
20070282197 Bill et al. Dec 2007 A1
20070299352 Harlev et al. Dec 2007 A1
20080008745 Stinchcomb et al. Jan 2008 A1
20080009720 Schefelker et al. Jan 2008 A1
20080015442 Watson et al. Jan 2008 A1
20080027320 Bolorforosh et al. Jan 2008 A1
20080045908 Gould et al. Feb 2008 A1
20080051626 Sato et al. Feb 2008 A1
20080081958 Denison et al. Apr 2008 A1
20080082136 Gaudiani Apr 2008 A1
20080097232 Rothenberg Apr 2008 A1
20080108949 Beasley et al. May 2008 A1
20080114095 Peppmoller et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080139944 Weymer et al. Jun 2008 A1
20080146939 McMorrow et al. Jun 2008 A1
20080146940 Jenkins et al. Jun 2008 A1
20080154100 Thalmeier et al. Jun 2008 A1
20080166453 Steele et al. Jul 2008 A1
20080171934 Greenan et al. Jul 2008 A1
20080183075 Govari et al. Jul 2008 A1
20080200754 Buchalter Aug 2008 A1
20080228082 Scheirer et al. Sep 2008 A1
20080255404 Nogawa et al. Oct 2008 A1
20080255475 Kondrosky et al. Oct 2008 A1
20080275765 Kuchar Nov 2008 A1
20090005675 Grunwald et al. Jan 2009 A1
20090018497 Birchard et al. Jan 2009 A1
20090024018 Boyden et al. Jan 2009 A1
20090043205 Pelissier et al. Feb 2009 A1
20090082661 Saladin et al. Mar 2009 A1
20090084382 Jalde et al. Apr 2009 A1
20090101577 Fulkerson et al. Apr 2009 A1
20090118612 Grunwald et al. May 2009 A1
20090118706 Schweikert et al. May 2009 A1
20090143736 Mittermeyer et al. Jun 2009 A1
20090156926 Messerly et al. Jun 2009 A1
20090163810 Kanade et al. Jun 2009 A1
20090171217 Kim et al. Jul 2009 A1
20090177083 Matsumura Jul 2009 A1
20090177090 Grunwald et al. Jul 2009 A1
20090204113 Macadam et al. Aug 2009 A1
20090209950 Starksen Aug 2009 A1
20090227952 Blakstvedt et al. Sep 2009 A1
20090234328 Cox et al. Sep 2009 A1
20090258171 Uang Oct 2009 A1
20090259124 Rothenberg Oct 2009 A1
20090262982 Markowitz et al. Oct 2009 A1
20090275828 Shachar et al. Nov 2009 A1
20090297441 Canham et al. Dec 2009 A1
20100004543 Ahlund et al. Jan 2010 A1
20100004547 Scholz et al. Jan 2010 A1
20100016726 Meier Jan 2010 A1
20100036227 Cox et al. Feb 2010 A1
20100049062 Ziv Feb 2010 A1
20100055153 Majmudar Mar 2010 A1
20100055184 Zeitels et al. Mar 2010 A1
20100057157 Govari et al. Mar 2010 A1
20100060472 Kimura et al. Mar 2010 A1
20100083719 Peppmoller et al. Apr 2010 A1
20100094116 Silverstein Apr 2010 A1
20100106011 Byrd et al. Apr 2010 A1
20100114573 Huang et al. May 2010 A1
20100143119 Kooijman et al. Jun 2010 A1
20100185097 Hall Jul 2010 A1
20100198048 Togawa Aug 2010 A1
20100204569 Burnside et al. Aug 2010 A1
20100217116 Eck et al. Aug 2010 A1
20100222664 Lemon et al. Sep 2010 A1
20100234733 Wahlheim Sep 2010 A1
20100249598 Smith et al. Sep 2010 A1
20100258033 Yang et al. Oct 2010 A1
20100273895 Stinchcomb et al. Oct 2010 A1
20100298702 Rogers et al. Nov 2010 A1
20100317981 Grunwald Dec 2010 A1
20100318026 Grunwald Dec 2010 A1
20100331712 Rothenberg Dec 2010 A1
20110015527 Heasty et al. Jan 2011 A1
20110015533 Cox et al. Jan 2011 A1
20110040212 Dietz et al. Feb 2011 A1
20110052694 Stinchcomb et al. Mar 2011 A1
20110087107 Lindekugel et al. Apr 2011 A1
20110196248 Grunwald Aug 2011 A1
20110282188 Burnside et al. Nov 2011 A1
20110295108 Cox et al. Dec 2011 A1
20110313293 Lindekugel et al. Dec 2011 A1
20120046562 Powers et al. Feb 2012 A1
20120059270 Grunwald Mar 2012 A1
20120095319 Kondrosky et al. Apr 2012 A1
20120108950 He et al. May 2012 A1
20120143029 Silverstein et al. Jun 2012 A1
20120220854 Messerly et al. Aug 2012 A1
Foreign Referenced Citations (130)
Number Date Country
642647 Nov 1990 AU
5586590 Nov 1990 AU
1860597 Jun 1999 AU
20009592 Sep 2000 AU
20015250 Jun 2001 AU
2001283703 May 2002 AU
768362 Dec 2003 AU
2001229024 Sep 2005 AU
2001283703 May 2006 AU
2006202149 Jun 2006 AU
2006904933 Sep 2006 AU
2006283022 Feb 2012 AU
2420676 Feb 2002 CA
102209490 Oct 2011 CN
4319033 Jun 1994 DE
0359697 Mar 1990 EP
0362821 Apr 1990 EP
0399536 Nov 1990 EP
0823261 Feb 1998 EP
0928976 Jul 1999 EP
1504713 Feb 2005 EP
1311226 Aug 2008 EP
2313143 Apr 2011 EP
2440122 Apr 2012 EP
2464407 Jun 2012 EP
2482719 Aug 2012 EP
2545349 Nov 1984 FR
01097440 Apr 1989 JP
03173542 Jul 1991 JP
4090741 Aug 1992 JP
4505748 Oct 1992 JP
09-094298 Apr 1997 JP
10043310 Feb 1998 JP
10290839 Nov 1998 JP
11128237 May 1999 JP
2001161683 Jun 2001 JP
2001340334 Dec 2001 JP
2003501127 Jan 2003 JP
2003061752 Mar 2003 JP
2003299654 Oct 2003 JP
2003334191 Nov 2003 JP
2002520893 Feb 2004 JP
2004505748 Feb 2004 JP
2004515298 May 2004 JP
2006508744 Mar 2006 JP
5010604 Jun 2012 JP
2012-529929 Nov 2012 JP
9002514 Mar 1990 WO
WO-9002514 Mar 1990 WO
9112836 Sep 1991 WO
WO-9203090 Mar 1992 WO
9403159 Feb 1994 WO
WO-9404938 Mar 1994 WO
9605768 Feb 1996 WO
9607352 Mar 1996 WO
WO-9641119 Dec 1996 WO
9729683 Aug 1997 WO
9743989 Nov 1997 WO
9916495 Apr 1999 WO
9949407 Sep 1999 WO
WO-0019906 Apr 2000 WO
WO-0040155 Jul 2000 WO
0074775 Dec 2000 WO
0176479 Oct 2001 WO
WO-0215973 Feb 2002 WO
0225277 Mar 2002 WO
WO-02094102 Nov 2002 WO
WO-03061752 Jul 2003 WO
03077759 Sep 2003 WO
2004049970 Jun 2004 WO
WO-2005033524 Apr 2005 WO
WO-2005033574 Apr 2005 WO
2005117690 Dec 2005 WO
WO-2006031765 Mar 2006 WO
WO-2006031765 Mar 2006 WO
WO-2006074509 Jul 2006 WO
WO-2006074510 Jul 2006 WO
WO-2006074510 Jul 2006 WO
WO-2006078677 Jul 2006 WO
WO-2006078677 Jul 2006 WO
2006103661 Oct 2006 WO
2007002541 Jan 2007 WO
2007005976 Jan 2007 WO
2007014447 Feb 2007 WO
2007034196 Mar 2007 WO
2007067324 Jun 2007 WO
2007069168 Jun 2007 WO
2007109123 Sep 2007 WO
2007144894 Dec 2007 WO
2008005480 Jan 2008 WO
2008024596 Feb 2008 WO
WO-2008028253 Mar 2008 WO
WO-2008083111 Jul 2008 WO
2008126074 Oct 2008 WO
2008131017 Oct 2008 WO
2008136008 Nov 2008 WO
2009002514 Dec 2008 WO
2009009064 Jan 2009 WO
2009057774 May 2009 WO
2009070616 Jun 2009 WO
WO-2009070836 Jun 2009 WO
WO-2009100158 Aug 2009 WO
2009123819 Oct 2009 WO
2009126340 Oct 2009 WO
2009129475 Oct 2009 WO
2009129477 Oct 2009 WO
2009134605 Nov 2009 WO
2009137262 Nov 2009 WO
2010002313 Jan 2010 WO
2010018500 Feb 2010 WO
2010022370 Feb 2010 WO
2010027349 Mar 2010 WO
2010027471 Mar 2010 WO
2010030820 Mar 2010 WO
2010132857 Nov 2010 WO
2010143196 Dec 2010 WO
2010144922 Dec 2010 WO
2011019760 Feb 2011 WO
2011041450 Apr 2011 WO
2011044421 Apr 2011 WO
2011064209 Jun 2011 WO
2011084593 Jul 2011 WO
2011097312 Aug 2011 WO
2011128052 Oct 2011 WO
2011150358 Dec 2011 WO
2012021542 Feb 2012 WO
2012024577 Feb 2012 WO
2012058461 May 2012 WO
2012083245 Jun 2012 WO
2012088535 Jun 2012 WO
Non-Patent Literature Citations (240)
Entry
“Ascension to Launch New 3D Guidance™ Tracker at TCT 2006.” Press Releases from Ascension website: www.ascension-tech.com/news/press—101106.php.
Andropoulos, et al. “A Controlled Study of the Transesophageal Echocardiography to Guide Central Venous Catheter Placement in Congetital Heart Surgery Patients.” The International Anesthesia Research Society, vol. 89, pp. 65-70, 1999.
Aslamy, et al. “MRI of Central Venous Anatomy: Implications for Central Venous Catheter Insertion.” American College of Chest Physicians, Jun. 8, 2009.
Aurora® System Technical Specifications.
B.Braun Website, “The Optimal Position of the Central Venous Catheter.” http://www.cvcpartner.com/index.cfm/8F1BDEA1310466194960A39F4E90968 (2009).
Cavatorta, et al., “Central Venous Catheter Placement in Hemodialysis: Evaluation of Electrocardiography Using a Guidewire.” The Journal of Vascular Access, vol. 2, pp. 45-50, 2001.
Chaturvedi et al., “Catheter Malplacement During Central Venous Cannulation Through Arm Veins in Pediatric Patients.” Journal of Neurosurgical Anesthesiology, vol. 15, No. 3 pp. 170-175, Jan. 2003.
Chu, et al., “Accurate Central Venous Port-A Catheter Placement: Intravenous Electrocardiography and Surface Landmark Techniques Compared by Using Transesophageal Echocardiography.” The International Anesthesia Research Society, vol. 98, pp. 910-914, 2004.
Clifford, et al. “Assessment of Hepatic Motion Secondary to Respiration for Computer Assisted Interventions.” Computer Aided Surgery, vol. 7, pp. 291-299, 2002.
Corsten, et al., “Central Placement Catheter Placement Using the ECG-Guided Cavafix-Certodyn SD Catheter.” Journal of Clinical Anesthesiology, vol. 6, Nov./Dec. 1994.
David, et al., “Is ECG-Guidance a Helpful Method to Correctly Position a Central Venous Catheter During Prehospital Emergency Care?” Acta Anaesthesiologica Scandinavica, vol. 49, pp. 1010-1014, 2005.
Deltec Cath-Finder® Tracking System Operation Manual, 1994.
Gebhard, et al., “The accuracy of Electrocardiogram-Controlled Central Line Placement.” The International Anesthesia Research Society, vol. 104, No. 1 Jan. 2007.
Gonzales, et al. “Peripherally Inserted Central Catheter Placement in Swine Using Magnet Detection.” Journal of Intravenous Nursing, vol. 22, No. 3, May/Jun. 1999.
Hoffmann, et al. “New Procedure in Transesophageal Echocardiography: Multiplane Transesophageal Echocardiography and Transesophageal Stress Echocardiography.” Herz, vol. 18, No. 5, pp. 269-277, Oct. 1993.
Madan, et al. “Right Atrial Electrocardiography: A Technique for the Placement of Central Venous Catheters for Chemotherapy or Intravenous Nutrition.” British Journal of Surgery, vol. B1, pp. 1604-1605, 1994.
Mcgee et al., “Accurate Placement of Central Venous Catheters: A Prospective, Randomize, Multicenter Trail.” Critical Care Medicine, vol. 21 No. 8, Aug. 1993.
Microbird™ Miniaturized DC Magnetic Sensors for Intra-body Navigation and Localization, Specifications, 2005.
Micronix CathRite™ Cardiac Access Device Brochure.
Neurometer® CPT, Clinical Applications. Neurotron , Inc. wesbite: www.neurotron.com/CLINAPS.html.
Neurometer® CPT, Frequently Asked Questions. Neurotron , Inc. wesbite: www.neurotron.com/CPTFAQ/html.
Neurometer® CPT, Products Page. Neurotron , Inc. wesbite: www.neurotron.com/products.html.
Neurometer® Electrodiagnostic Neuroselective Sensory Nerve Evaluation: Charts, Tables, Documents & Downloads. Neurotron , Inc. wesbite: www.neurotron.com/downloads.html.
Pawlik, et al., “Central Venous Catheter Placement: Comparison of the Intravascular Guidewire and the Fluid Column Electrocardiograms.” European Journal of Anaesthesiology, vol. 41, pp. 594-599, 2004.
Pittiruti, et al. “The EKG Method for Positioning the Tip of PICCs: Results from Two Preliminary Studies.” JAVA, vol. 13, No. 4, pp. 179-185, 2008.
Sacolick, et al. “Electromagnetically Tracked Placement of a Peripherally Inserted Central Catheter.” SPIE Medical Imaging, 2004 Proceedings.
Salem, et al. “A New Peripherally Implanted Subcutaneous Permanent Central Venous Access Device for Patients Requiring Chemotherapy.” Journal of Clinical Oncology, vol. 11, No. 11, pp. 2181-2185, Nov. 1993.
Schafer et al. “Incorrect placement of a vena cava catheter and its prevention by intra-atrial ECG.” Anaesthesist. Jan. 1988;37(1):49-51.
Schummer, et al. “Central Venous Catheters—The inability of ‘intra-atrial ECG’ to prove adequate positioning.” British Journal of Anaesthesia, vol. 93, No. 2, pp. 193-198, 2004.
Simon, et al., “Central Venous Catheter Placement in Children: Evaluation of Electrocardiography Using J-Wire.” Paediatric Anaesthesia vol. 9, pp. 501-504, 1999.
Starkhammar et al. “Cath-Finder Catheter Tracking System: A New Device for Positioning of Central Venous Catheters. Early Experience from Implantation of Brachial portal Systems.” Acta Anaesthesiol Scandinavia, vol. 34, No. 4 pp. 296-300.
Stererotaxis Magetic Navigation System with Navigant™ User Interface, 2005 Brochure.
Traxal Technologies, Tracking Technology website overview: www.traxal.com/rd/rd—classroom—trackingtechnology.htm.
Viasys Health Care Inc. Cortrak © Fact Sheet.
Viasys MedSystems, Cortrak™ Systems Brochure.
Watters, et al. “Use of Electrocardiogram to Position Right Atrial Catheters During Surgery.” Annals of Surgery, vol. 225, No. 2, pp. 165-171, 1997.
Worley, Seth J. “Use of a Real-Time Three-Dimensional Magenetic Navigation System for Radiofrequency Ablation of Accessory Pathways.” PACE, vol. 21 pp. 1636-1643, Aug. 1998.
Zaaroor, et al. “Novel Magnetic Technology for Intraoperative Intracranial Frameless Navigation: in Vivo and in Vitro Results.” Neurosurgery, vol. 48, No. 5. pp. 1100-1107, May 2001.
Hoffman, Thomas et al, Simultaneous Measurement of Pulmonary Venous Flow by Intravascular Catheter Doppler Velocimetry and Transesophageal Doppler Echocardiography: Relation to Left Atrial Pressure and Left Atrial and Left Ventricular Function, pp. 239-249, J Am Coll Cardiol, Jul. 1995.
Iacopino, Domenico Gerardo et al, Intraoperative Microvascular Doppler Monitoring of Blood Flow within a Spinal Dural Arteriovenous Fistula: A Precious Surgical Tool, vol. 10, 5 pages, Neurosurg. Focus, Feb. 2001.
Kim, Ko et al, Positioning Internal Jugular Venous Catheters using the Right Third Intercostal Space in Children, Acta Anaesthesiol Scand, pp. 1284-1286, vol. 47 No. 10, Nov. 2003.
Kjelstrup T et al, Positioning of Central Venous Catheters using ECG, Tidssk Nor Laegeforen, pp. 599-601, vol. 111 No. 5, Feb. 1999 (Abstract only).
Kowalski, CM et al, Migration of Central Venous Catheters: Implications for Initial Catheter Tip Positioning, J Vasc Intery Radiol , pp. 443-447, vol. 8 No. 3, May-Jun. 1997.
Leowenthal, MR et al, The Peripherally Inserted Central Catheter (PICC): A Prospective Study of its Natural History after Fossa Insertion, Anaesth Intensive Care, pp. 21-24; vol. 30 No. 1, Feb. 2002.
Lepage Ronan et al. ECG Segmentation and P-wave Feature Extraction: Application to Patients Prone to Atrial Fibrillation, IEEE/EMBS Proceedings, 23rd Annual Conference, Istanbul, Turkey, Oct. 25-28, 2001.
Liu , Ji-Bin et al, Catheter-Based Intralumincal Sonography, J Ultrasound Med, pp. 145-160, vol. 23, 2004.
Lucey, B et al, Routine Chest Radiographs after Central Line Insertion: Mandatory Postprocedural Evaluation or Unnecessary Waste of Resources?, Cardiovasc Intervent Radio!, pp. 381-384, vol. 22 No. 5, Sep.-Oct. 1999.
Lynch, RE et al, A Procedure for Placing Pediatric Femoral Venous Catheter Tips near the Right Atrium, Pediatr Emerg Care, pp. 130-132, vol. 18 No. 2, Apr. 2002.
Madias, John E, Intracardiac (Superior Vena Cava/Right Atrial) ECGs using Saline Solution as the Conductive Medium for the Proper Positioning of the Shiley Hemodialysis Catheter: Is it Not Time to Forego the Postinsertion Chest Radiograph?, pp. 2363-2367, CHEST, 2003.
Martin, Roy W, An Ultrasoundic Catheter for Intravascular Measurement of Blood Flow: Technical Details, IEEE Transactions on Sonics and Ultrasonics, vol. SU-27, No. 6, pp. 277-286, Nov. 1980.
McDonnall, “Intra-Atrial Electrocardiography (ECG) for Catheter Placement.” Literature review prepared for Bard Access Systems, Oct. 2007.
MedGraphics, CardioPerfect® Resting/Stress ECG System, 3 pages, 2001.
Michaels, Andrew D et al, Intravenous Electrocardiographic Guidance for Placement of Peripherally Inserted Central Catheters, pp. 274-278, vol. 43, Journal of Electrocardiology, 2010.
Michenfelder, John et al, Air Embolism During Neurosurgery—An Evaluation of Right-Atrial Catheters for Diagnosis and Treatment, JAMA, pp. 1353-1358, vol. 208, No. 8, May 26, 1969.
Michenfelder, John et al, Air Embolism During Neurosurgery . . . A New Method of Treatment, Anesthesia and Analgesia . . . Current Researches, pp. 390-395, vol. 45, No. 4, Jul.-Aug. 1966.
Micronix Pty Ltd “CathRite” Guiding Styled Core Manufacturing, Jun. 15, 2006.
Murthy, Vrudhula et al, Analysis of Power Spectral Densities of Electrocardiograms, Mathematical Biosciences, pp. 41-51, vol. 12 No. 1-2, Oct. 1971.
Nadroo, AM et al, Changes in Upper Extremity Position Cause Migration of Peripherally Inserted Central Catheters in Neonates, Pediatrics, pp. 131-136, vol. 110, Jul. 2002.
Nakatani, K et al, Accurate Placement of Central Venous Catheters—ECG-guided method vs Patient Height Method, Masui, pp. 34-38, vol. 51 No. 1, Jan. 2002.
Nazarian, GK et al, Changes in Tunneled Catheter Tip Position when a patient is Upright, J Vasc Intery Radiol, pp. 437-441, vol. 8 No. 3, May-Jun. 1997.
Odd, DE et al, Does Radio-opaque Contrast Improve Radiographic localisation of Percutaneous Central Venous Lines?, Arch Dis Child Fetal Neonatal Ed, pp. 41-43, vol. 89 No. 1, Jan. 2004.
Palesty, JA et al, Routine Chest Radiographs Following Central Venous Recatherization over a Wire are not Justified, Am J Surg, pp. 618-621, vol. 176 No. 6, Dec. 1998.
Paliotti, Roberta P. et al, Intravascular Doppler Technique for Monitoring Renal Venous Blood Flow in Man, J Nephrol, pp. 57-62, 2003.
Parker, K.H. et al, Cardiovascular Fluid Dynamics, Department of Bioengineering, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Cardiovascular Haemodynamics, pp. 1-28, Sep. 26, 2005.
PCT/US2006/033079 filed Aug. 24, 2006 International Preliminary Report on Patentability dated Feb. 26, 2008.
PCT/US2006/033079 filed Aug. 24, 2006 Search Report dated Dec. 19, 2006.
PCT/US2006/033079 filed Aug. 24, 2006 Written Opinion dated Dec. 19, 2006.
PCT/US2008/084751 filed Nov. 25, 2008 International Preliminary Report on Patentability dated Jun. 1, 2010.
PCT/US2008/084751 filed Nov. 25, 2008 Search Report dated May 20, 2009.
PCT/US2008/084751 filed Nov. 25, 2008 Written Opinion dated May 20, 2009.
PCT/US2009/033116 filed Feb. 4, 2009 International Preliminary Report on Patentability dated Aug. 10, 2010.
PCT/US2009/033116 filed Feb. 4, 2009 Search Report dated Mar. 13, 2009.
PCT/US2009/033116 filed Feb. 4, 2009 Written Opinion dated Mar. 13, 2009.
PCT/US2009/041051 filed Apr. 17, 2009 Search Report dated Jul. 28, 2009.
PCT/US2009/041051 filed Apr. 17, 2009 Written Opinion dated Jul. 28, 2009.
PCT/US2009/054687 filed Aug. 21, 2009 International Preliminary Report on Patentability dated Feb. 22, 2011.
PCT/US2009/054687 filed Aug. 21, 2009 Written Opinion dated Oct. 6, 2009.
PCT/US2009/056567 filed Sep. 10, 2009 International Preliminary Report on Patentability dated Mar. 15, 2011.
PCT/US2009/056567 filed Sep. 10, 2009 Search Report dated Nov. 6, 2009.
PCT/US2009/056567 filed Sep. 10, 2009 Written Opinion dated Nov. 6, 2009.
PCT/US2010/038555 filed Jun. 14, 2010 Search Report dated Oct. 5, 2010.
PCT/US2010/038555 filed Jun. 14, 2010 Written Opinion dated Oct. 5, 2010.
PCT/US2010/045084 filed Aug. 10, 2010 Search Report dated Apr. 14, 2011.
PCT/US2010/050773 filed Sep. 29, 2010 Search Report dated Jan. 24, 2011.
PCT/US2010/050773 filed Sep. 29, 2010 Written Opinion dated Jan. 24, 2011.
PCT/US2010/051917 filed Oct. 8, 2010 Search Report dated Nov. 29, 2010.
PCT/US2010/051917 filed Oct. 8, 2010 Written Opinion dated Nov. 29, 2010.
PCT/US2011/023497 filed Feb. 2, 2011 Search Report dated Jun. 6, 2011.
PCT/US2011/023497 filed Feb. 2, 2011 Written Opinion dated Jun. 6, 2011.
Pennington, C.R., Right Atrial Thrombus: A Complication of Total Parenteral Nutrition, British Medical Journal, pp. 446-447, vol. 295, Aug. 15, 1987.
Perez, Valdivieso Jr et al, Evaluation of a Formula for Optimal Positioning of a Central Venous Catheter through the Right Internal Jugular Vein, Rev Esp Anestesiol Reanim, pp. 77-79, vol. 50 No. 2, Feb. 2003.
Petersen, J et al, Silicone Venous Access Devices Positioned with their Tip High in the Superior Vena Cava are More Likely to Malfunction, Am J Surg, pp. 38-41, vol. 178 No. 1, Jul. 1999.
Pittiruti, et al, Intracavitary EKG Monitoring: A reliable method for controlling tip position during and after PICC Insertion presentation in Catholic University, Rome, Italy in 2008.
Polos, PG et al, Tips for Monitoring the Position of a Central Venous Catheter—How Placement can go awry—even when the anatomy is normal, J Crit Illn, pp. 660-674, vol. 8 No. 6, Jun. 1993 (Abstract only).
Randolph AG et al, Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature, Critcal Care Medicine, pp. 2053-2058, vol. 24, Dec. 1996.
Reece, A et al, Posititioning Long Lines: Contrast Versus Plain Radiography, Arch Dis Child Fetal Neonatal Ed, pp. 129-130, vol. 84 No. 2, Mar. 2001.
Reynolds, N et al, Assessment of Distal Tip Position of Long Term Central Venous Feeding Catheters using Transesophageal Echocardiology, JPEN J Parenter Enteral Nutr, pp. 39-41, vol. 25 No. 1, Jan.-Feb. 2001.
Ruschulte, Heiner et al, Prevention of Central Venous Catheter related infections with chlorhex idine gluconate impregnated wound dressings: A randomized controlled trial, presented as an abstract at the Annual meeting of the European Society of Anaesthesiologists (ESA) in Madrid, Spain in Jun. 2006, 12 pages, Annals of Hematology, Jul. 14, 2008.
Savary, D et al, Intra-atrial Monitoring to Add Insertion of a Central Venous Line in Pre-Hospital Emergency Care Journal Europeen des Urgences, pp. 75-78, vol. 17 No. 2, 2004.
Schummer, W et al, ECG-guided Central Venous Catheter Positioning: Does it detect the Pericardial Reflection rather than the Right Atrium?, Eur J Anaesthesiol, pp. 600-605, vol. 21 No. 8, Aug. 2004 (Abstract only).
Schummer, W et al, Intra-Atrial ECG is not a Reliable Method for Positioning Left Internal Jugular Vein Catheters, Br J Anaesth, pp. 481-486, vol. 91 No. 4, Oct. 2003.
Schummer, W, Central Venous Catheter—The Inability of “Intra-Atrial ECG” to prove Adequate Positioning, Br J Anaesth, pp. 193-198, vol. 93 No. 2, Aug. 2004.
Stark, DD et al, Radiographic Assessment of Venous Catheter Position in Children: Value of the Lateral View, Pediatric Radiology, pp. 76-80, vol. 14 No. 2, 1984.
Starkhammer, H et al, Central Venous Catheter Placement using Electromagnetic Position Sensing: A Clinical Evaluation, Biomed. Instrum Technol, vol. 30 No. 2, pp. 164-170; Mar.-Apr. 1996.
Starr, David S et al, EKG Guided Placement of Subclavian CVP Catheters Using J-Wire, pp. 673-676, Ann. Surg, Dec. 1986.
Stas, M et al, Peroperative Intravasal Electrographic Control of Catheter Tip Position in Access Ports Placed by Venous Cut-Down Technique, EJSO, pp. 316-320, vol. 27, 2001.
Stereotaxis, Expanding the Possibilites of Interventional Medicine: Remote Navigation and Automation, pp. 1-8.
Tepa® Health Innovation PC based ECG System Introduction and Technical Specifications, EKG Master USB, 2 pages, Nov. 2003.
The FloWire Doppler Guide Wire located <http://www.volcanocorp.com/products/flowire-doppler-guide-wire.php>, 2011.
UAB Health Systems, Arrhythmias, retrieved from http://www.health.uab.edu/14564/ on Nov. 15, 2007, 12 pages.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Advisory Action dated Jun. 22, 2009.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Final Office Action dated Apr. 8, 2010.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Final Office Action dated Jan. 30, 2009.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Non-Final Office Action dated Sep. 25, 2009.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Non-Final Office Action dated Apr. 27, 2009.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Notice of Allowance dated May 20, 2010.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Notice of Allowability dated Apr. 2, 2010.
VasoNova Inc, Vascular navigation system for accurate placement of PICCs, Start-Up Emerging Medical Ventures, pp. 44-45, vol. 14 No. 7, Jul.-Aug. 2009.
Viasys Healthcare MedSystems, Navigator® Benefits, 2008.
Viasys Healthcare MedSystems, Navigator® Research in Cost Justification, 2008.
Volcano ComboMap Features and Benefits/Technical Specifications, 2 pages.
Welch Allyn Cardioperfect® PC-Based Resting ECG, 2003.
Wilson, R. G. et al, Right Atrial Electrocardiography in Placement of Central Venous Catheters, The Lancet, pp. 462-463, Feb. 27, 1988.
Yilmazlar A et al, Complications of 1303 Central Venous Cannulations, J R Soc Med, pp. 319-321, vol. 90 No. 6, Jun. 1997 (Abstract only).
Yoon, SZ et al, Usefulness of the Carina as a Radiographic Landmark for Central Venous Catheter Placement in Paediatric Patients, Br J Anaesth, Jul. 2005.
Yoshida, Teruhisa et al, Detection of Concealed Left Sided Accessory Atrioventricular Pathway by P Wave Signal Averaged Electrocardiogram, J Am Coll Cardiol, pp. 55-62, 1999.
Acuson—The Value of Vision, AcuNav Diagnostic Ultrasound Catheter, 2000.
Advertising flyer for GAVECELT—The Italian Group for Long Term Venous Access Devices, for program on International Meeting on PICC's, Midline Catheters and Long Term Venous Access Devices in Catholic University, Rome, Italy on Dec. 3, 4, 5, 2008.
Alexander, GD et al, The Role of Nitrous Oxide in Postoperative Nausea and Vomiting, Collection of Abstracts Presented at the International Anesthesia Research Society by various speakers, 58th Congress, Mar. 12-14, 1984, Anesthesia and Analgesia, pp. 175-284, vol. 63, 1984.
Allan, P.L. et al, Role of Ultrsound in the Assessment of Chronic Venous Insufficiency, Ultrasound Quarterly, vol. 17, No. 1, pp. 3-10, 2001.
Anonymous author, Correct Catheter Placement with a low-impact, reliable and economical method.
Arai, J et al, Detection of Peripherally Inserted Central Catheter Occlusion by in-line Pressure Monitoring, Paediatr Anaesth, pp. 621-624, vol. 12 No. 7, Sep. 2002.
Arrow International, Inc., The Arrow-Johans RAECG Adapter-Making Proper Central Venous Catheter Placement More Reliable (Modle No. EG-04900), Technical Report 1987, USA.
AU 2006283022 filed Aug. 24, 2006 Office Action dated Dec. 22, 2010.
B. Braun, Certofix Central Venous Catheter for Placement Using the Seldinger Technique with Simultaneous ECG Lead Option.
Bailey, SH et al, Is Immediate Chest Radiograph Necessary after Central Venous Catheter Placement in a Surgical Intensive Care Unit?, Am J Surg, pp. 517-522, vol. 180 No. 6, Dec. 2000.
Barber, JM et al, A Nurse led Peripherally Inserted Central Catheter Line Insertion Service is Effective with Radiological Support, Clin Radiol, pp. 352-354, vol. 57 No. 5, May 2002.
Bard Access Systems, Sherlock Tip Location System, 5 pages, 2006.
Bard Access Systems, Site Rite Vascular Acess Ultrasound System, 4 pages, 2005.
Benchimol, Alberto at al, Right Atrium and Superior Vena Cava Flow Velocity in Man Measured with the Doppler Catheter Flowmeter-Telemetry System, The Amer Journal of Medicine, pp. 303-309, vol. 48, Mar. 1970.
BioAdvance Lumen Vu, Greenhouse Fund Feb. 2004 Recipient, www.bioadvance.com <http://www.bioadvance.com>, 2005.
Borgobello, Bridget, App allows users to view electrocardiograms on smartphones dated Oct. 15, 2010; printed from http://www.gizmag.com/app-to-view-electrocardiograms-on-smartphones/16664/ on Feb. 4, 2011.
Buehrle, Douglas, PICC Placement in Humans using Electromagnetic Detection, <http://www.corpakmedsystems.com/supplement—material/supplementpages/navigator/navarticle.html>, 2008.
C.R. Bard, CathTrack™ Catheter Location System at www.bardaccess.com <http://www.bardaccess.com>.
C.R. Bard, Inc., Bard Electrophysiology Product Catalogue, Bard Catheters, pp. 74-75 (2002), USA.
Cadman, A et al, To Clot or Not to Clot? That is the question in Central Venous Catheters, Clinical Radiology, pp. 349-355, vol. 59 No. 4, Apr. 2004.
Calvert, N et al, The Effectiveness and Cost-effectiveness of Ultrasound Locating Devices for Central Venous Access: A Systematic Review and Economic Evaluation, Health Technology Assessment, vol. 7, No. 12, 2003.
Carlon, R et al, Secondary Migration of a Central Venous Catheter—A Case Report, Minerva Anestesiol, pp. 927-931, vol. 69 No. 12, Dec. 2003.
Caruso, LJ et al, A Better Landmark for Positioning a Central Venous Catheter, J Clinical Monitoring and Computing, pp. 331-334, vol. 17 No. 6, Aug. 2002.
Chalkiadis, GA et al, Depth of Central Venous Catheter Insertion in Adults: An Audit and Assessment of a Technique to Improve Tip Position, Anaesth Intensive Care, pp. 61-66, vol. 26 No. 1, Feb. 1998.
Chamsi-Pasha, Hassan et al, Cardiac Complications of Total Parenteral Nutrition: The Role of Two-Dimensional Echocardiography in Diagnosis, Annals of the Royal College of Surgeons of England, pp. 120-123, vol. 71, 1989.
Chen, Zhongping et al, Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy, 7 pages, vol. 67, Photochemistry and Photobiology, 1998.
Cheng, Ki et al, A Novel Approach of Intravenous Electrocardiograph Technique in Correct Position the Long-Term Central Venous Catheter, Kaohsiung J Med Sci, pp. 241-247, vol. 16 No. 5, May 2000 (Abstract only).
Claasz, Antonia et al, A Study of the Relationship of the Superior Vena Cava to the Bony Landmarks of the Sternum in the Supine Adult: Implications for Magnetic Guidance Systems, Journal, vol. 12 No. 3, JAVA, Jul. 24, 2007.
Colley, Peter S et al, ECG-Guided Placement of Sorenson CVP Catheters via Arm Veins, Anesthesia and Analgesia, pp. 953-956, vol. 63, 1984.
Collier, PE et al, Cardiac Tamponade from Central Venous Catheters, Am J Surg, pp. 212-214, vol. 176 No. 2, Aug. 1998.
ComboWire® Pressure/Flow Guide Wire Ref 9500 Series, 36 pages, (information in different languages).
Cucchiara, Roy et al, Time Required and Success Rate of Percantaneous Right Atrial Catherization: Description of a Technique, Canad. Anaesth. Soc. J., pp. 572-573, vol. 27, No. 6, Nov. 1980.
Cullinane, DC et al, The Futility of Chest Roentgenograms Following Routine Central Venous Line Changes, Am J Surg, pp. 283-285, vol. 176 No. 3, Sep. 1998.
Egelhof, Petra, Effects of Somatostatin on Portal Blood Flow and Portal Vein Pressure in Patients with Portal Hypertension due to Liver Cirrhosis Invasive Monitoring during TIPSS Procedures, Dissertation submitted to: Technical University of Munich, Faculty of Medicine, May 13, 2002; Date of examination: Feb. 26, 2003.
Engelhardt, W et al, ECG-Controlled Placement of Central Venous Catheters in Patients with Atrial Fibrallation, Anaesthesist, pp. 476-479, vol. 38 No. 9, Sep. 1989 (Abstract only).
Fearon, William F et al, Evaluating Intermediate Coronary Lesions in the Cardiac Catheterization Laboratory, vol. 4, No. 1, 7 pages, Reviews in Cardiovascular Medicine, 2003.
Felleiter P et al, Use of Electrocardiographic Placement Control of Central Venous Catheters in Austria, Acta Med Austriaca, pp. 109-113, vol. 26 No. 3, 1999 (Abstract only).
Forauer, AR et al, Change in Peripherally Inserted Central Catheter Tip Location with Abduction and Adduction of the Upper Extremity, J Vasc Intery Radiol , pp. 1315-1318, vol. 11 No. 10, Nov.-Dec. 2000.
Frassinelli, P et al, Utility of Chest Radiographs after Guidewire Exchanges of Central Venous Catheters, Crit Care Med, pp. 611-615, vol. 26 No. 3, Mar. 1998.
Frazin L et al, A Doppler Guided Retrograde Catheterization System, Cathet. Cardiovasc Diagn, pp. 41-50, May 1992.
French, PJ et al, Sensors for Catheter Applications, Sensors Update, vol. 13 Issue 1 pp. 107-153, Dec. 2003.
GB Application 0800474.9 filed Aug. 24, 2006 Office Action dated Aug. 9, 2010.
GB Application 0800474.9 filed Aug. 24, 2006 Office Action dated Mar. 17, 2010.
Gebauer, B et al, Ultrasound and Fluoroscopy-guided Implantation of Peripherally Inserted Central Venous Catheters (PICCs), ROFO, pp. 386-391, vol. 176 No. 3, Mar. 2004 (Abstract only).
Gladwin, MT et al, Cannulation of the Internal Jugular Vein: is postpocedural chest radiography always necessary?, Crit Care Med, 33 pages, Oct. 2000.
Greenall, M.J. et al, Cardiac Tamponade and Central Venous Catheters, British Medical Journal, pp. 595-597, Jun. 14, 1975.
Guillory, “Basic Principles of Technologies for Catheter Localization.” C.R. Bard internal paper, Oct. 20, 2004.
Guth, AA, Routine Chest X-rays after Insertion of Implantable Long-Term Venous Catheters: Necessary or Not?, Am Surg, pp. 26-29, vol. 67 No. 1, Jan. 2001 (Abstract only).
Hill, Bradley et al, Abstract of article discussing Vasallova VPS as guide for placement of PICCs.
Hill, Bradley, Identifying the Caval-Atrial Junction Using Smart-Catheter Technology presentation, 22nd Annual Scientific Meeting of the AVA in Savannah, Georgia, Sep. 13, 2008.
U.S. Appl. No. 12/427,244, filed Apr. 21, 2009 Non-Final Office Action dated Jan. 19, 2012.
U.S. Appl. No. 12/545,762, filed Aug. 21, 2009 Non-Final Office Action dated Aug. 1, 2012.
U.S. Appl. No. 12/557,401, filed Sep. 10, 2009 Non-Final Office Action dated Apr. 24, 2012.
U.S. Appl. No. 12/575,456, filed Oct. 7, 2009 Non-Final Office Action dated Oct. 5, 2012.
U.S. Appl. No. 12/715,556, filed Mar. 2, 2010 Non-Final Office Action dated Sep. 13, 2012.
U.S. Appl. No. 12/878,915, filed Sep. 9, 2010 Final Office Action dated Sep. 26, 2012.
U.S. Appl. No. 12/878,915, filed Sep. 9, 2010 Non-Final Office Action dated Mar. 15, 2012.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Non-Final Office Action dated Oct. 3, 2012.
U.S. Appl. No. 13/213,622, filed Aug. 19, 2011 Non-Final Office Action dated Jul. 31, 2012.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Non-Final Office Action dated Oct. 16, 2012.
Valdivieso, J.R. Perez, et al., Evaluation of a formula for optimal positioning of a central venous catheter inserted through the right internal jugular vein, Rev. Esp. Anestesiol. Reanim. 2003; 50: 77-79.
Vesely, Thomas M. et al., Central Venous Catheter Tip Position: A Continuing Controversy, J Vasc Intery Radiol 2003; 14:527-534.
Wong, Jeffrey J. et al., Azygos Tip Placement for Hemodialysis Catheters in Patients with Superior Vena Cava Occlusion, Cardiovasc Intervent Radiol (2006) 29:143-146.
Zachariou, Zacharias et al., Intra-atrial ECG recording: a new and safe method for implantation of Broviac catheters in children, Pediatr Surg Int (1994) 9: 457-458.
Bankier, Alexander A., Azygos Arch Cannulation by Central Venous Catheters: Radiographic Detection of Malposition and Subsequent Complications, Journal of Thoracic Imaging 12:64-69 (1997).
CA 2,619,909 filed Aug. 24, 2006 Examiner's Report dated Oct. 26, 2012.
Cardella, John F. et al., Interventinal Radiologic Placement of Peripherally Inserted Central Catheters, Journal of Vascular and Interventional Radiology 1993; 4:653-660.
Chang, Thomas C. et al., Are Routine Ch Ladiographs Necessary After Image-Guided Placement of Internal Jugular Central Venous Access Devices?, AJR Feb. 1998;170:335-337.
Cheung, P., et al., The Effect of a Disposable Probe Cover on Pulse Oximetry, Anaesth Intensive Care 2002; 30: 211-214.
CN 200880012117.4 filed Apr. 16, 2008 First Office Action dated Dec. 23, 2011.
CN 200880012117.4 filed Apr. 16, 2008 Second Office Action dated Oct. 8, 2012.
CN 200880125528.4 filed Nov. 25, 2008 First Office Action dated Jun. 5, 2012.
Curet, Myriam J. et al., University and Practice-based Physicians' Input on the Content of a Surgical Curriculum, The American Journal of Surgery® vol. 178 Jul. 1999, 78-84.
EP 08855396.1 filed Jun. 15, 2010 European Search Report dated Jul. 31, 2012.
EP 09808901.4 filed Aug. 21, 2009 European Search Report dated May 23, 2012.
EP 09813632.8 filed Apr. 5, 2011 European Search Report dated Jul. 4, 2012.
Gjendemsjo, Anders, et al., Energy and Power, The Connexions Project, Version 1.2, Feb. 20, 2004.
Joosting, Jean-Pierre, “Dual-interface RFID-compatible EEPROM enables remote access to electronic device parameters,” EE Times, Mar. 8, 2010.
JP 2008-528151 filed Aug 24, 2006 Notice of Grant dated May 6, 2012.
JP 2010-504220 filed Sep. 3, 2009 Office Action dated May 21, 2012.
Kofler, Julia, et al., Epinephrine application via an endotracheal airway and via the Combitube in esophageal position, Critical Care Medicine: May 2000, vol. 28: Issue 5, pp. 1445-1449.
Konings, MK, et al., Development of an intravascular impedance catheter for detection of fatty lesions in arteries, IEEE Trans Med Imaging Aug. 1997; 16(4):439-46.
Lum, Phillip, A New Formula-Based Measurement Guide for Optimal Positioning of Central Venous Catheters, JAVA, vol. 9, No. 2, pp. 80-85, 2004.
Markovich, Mary B., Central Venous Catheter Tip Placement: Determination of Posterior Malposition—A Case Study, Java, vol. 11, No. 2, pp. 85-89, 2006.
PCT/US2008/060502 filed Apr. 16, 2008 International Search Report and Written Opinion dated Oct. 16, 2008.
PCT/US2009/054687 filed Aug. 21, 2009 Search Report dated Oct. 6, 2009.
PCT/US2010/045084 filed Aug. 10, 2010 International Preliminary Report on Patentability dated Feb. 23, 2012.
PCT/US2010/045084 filed Aug. 10, 2010 Written Opinion dated Apr. 14, 2011.
PCT/US2011/038391 filed May 27, 2011 International Preliminary Report on Patentability and Written Opinion dated Dec. 4, 2012.
PCT/US2011/038391 filed May 27, 2011 International Search Report dated Sep. 21, 2011.
PCT/US2011/038415 filed May 27, 2011 International Search Report dated Sep. 28, 2011.
PCT/US2011/038415 filed May 27, 2011 Written Opinion dated Sep. 28, 2011.
PCT/US2011/047127 filed Aug. 9, 2011 International Search Report dated Feb. 29, 2012.
PCT/US2011/047127 filed Aug. 9, 2011 Written Opinion dated Feb. 29, 2012.
PCT/US2011/048403 filed Aug. 19, 2011 International Search Report dated Dec. 15, 2011.
PCT/US2011/048403 filed Aug. 19, 2011 Written Opinion dated Dec. 15, 2011.
PCT/US2011/052793 filed Sep. 22, 2011 International Search Report dated Jan. 6, 2012.
PCT/US2011/052793 filed Sep. 22, 2011 Written Opinion dated Jan. 6, 2012.
PCT/US2011/058138 filed Oct. 27, 2011 International Search Report dated Feb. 7, 2012.
PCT/US2011/058138 filed Oct. 27, 2011 Written Opinion dated Feb. 7, 2012.
PCT/US2011/067268 filed Dec. 23, 2011 International Search Report and Written Opinion dated Apr. 27, 2012.
PCT/US2012/045814 filed Jul. 6, 2012 International Search Report and Written Opinion dated Oct. 1, 2012.
Pop, Gheorghe A. et al., Catheter-based impedance measurements in the right atrium for continuously monitoring hematocrit and estimating blood viscosity changes; an in vivo feasibility study in swine, Biosensors and Bioelectronics 19 (2004) 1685-1693.
Popp, M. B. et al., Accuracy of implanted port placement with the use of the electromagnetic CathTrack® catheter locator system, The Journal of Vascular Access 2005; 6: 9-12.
Rutherford, J. S. et al., Depth of Central Venous Catheterization: An Audit of Practice in a Cardiac Surgical Unit, Anaesth Intens Care 1994; 22: 267-271.
Schuster, M. et al., The carina as a landmark in central venous catheter placement, British Journal of Anaesthesia 85 (2): 192-4 (2000).
Siela, Debra, Using Chest Radiography in the Intensive Care Unit, Crit Care Nurse Aug. 1, 2002 vol. 22 No. 4, pp. 18-27.
Smith, Brigham, et al., Intravenous electrocardiographic guidance for placement of peripherally inserted central catheters, Journal of Electrocardiology 43 (2010) 274-278.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Appeal Board Decision dated Sep. 17, 2012.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Notice of Allowance dated Dec. 3, 2012.
U.S. Appl. No. 12/104,253, filed Apr. 16, 2008 Final Office Action dated Jul. 27, 2011.
U.S. Appl. No. 12/104,253, filed Apr. 16, 2008 Non-Final Office Action dated Nov. 29, 2010.
U.S. Appl. No. 12/323,273, filed Nov. 25, 2008 Non-Final Office Action dated Jun. 8, 2012.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Non-Final Office Action dated Dec. 3, 2012.
Related Publications (1)
Number Date Country
20090203989 A1 Aug 2009 US
Provisional Applications (1)
Number Date Country
61027710 Feb 2008 US